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A diagnosis of psychogenic nonepileptic seizures (PNES) should be considered, when 
evaluating children and adolescents presenting with seizure symptoms. PNES are 
commonly encountered in paediatric and neurological departments, and around 10% 
of patients presenting with seizures are expected to have PNES. PNES can present 
with symptoms that mimic epilepsy, and the diagnostic process is often challenging 
which may delay correct diagnosis, and lead to unnecessary clinical examinations and 
incorrect treatment with antiepileptic drugs. PNES are associated with emotional 
distress in affected patients and their families as well as impaired daily functioning 
with school absenteeism and social withdrawal. A burden of increased healthcare and 
social costs are also reported; still, patients are reportedly often neglected due to lack 
of relevant treatment options. 
In spite of the reported impact associated with PNES, knowledge on PNES in children 
and adolescents remains limited, as most prior studies have included only small 




The overall aim of this PhD project was to utilize the Danish nationwide patient 
registries to establish a large cohort of children and adolescents with PNES and 
thereby gain knowledge regarding incidence, characteristics and morbidity of 
childhood-onset PNES. The aims of the three studies included in the thesis were: 
1) To establish a cohort of children and adolescents with PNES and describe the 
presenting incidence rates and clinical characteristics as well as explore possible 
differences in clinical characteristics between PNES with and without comorbid 
epilepsy. (Study Ⅰ) 
2) To outline the spectrum and risk of psychiatric disorders in paediatric-onset PNES 
prior to and in the 2 years following their PNES diagnosis, as compared to children 
and adolescents with epilepsy and children and adolescents with no PNES or epilepsy 
(termed healthy controls). (Study Ⅱ) 
3) To describe the somatic and psychiatric hospital service use in children and 
adolescents with PNES 2 years before and 2 years after their PNES diagnosis, as 
compared to children and adolescents with epilepsy and healthy controls. (Study Ⅲ) 
 
Methods 
The PhD project consisted of three studies and was based on data from the Danish 
national registries and medical record data. Study Ⅰ was a nationwide retrospective 
cohort study of 5-17-year-old children and adolescents registered with an ICD-10 
diagnosis corresponding to PNES (i.e. F44.5 “Dissociative seizures” and/or R56.8G 
“Other and unspecified convulsions, non-epileptic seizures”) in the study period 1996-
2014. The medical record of each study participant was assessed to validate the PNES 
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diagnosis based on a rating of diagnostic certainty, and data on clinical characteristics 
were extracted from the medical records as well. Study Ⅱ and Study Ⅲ were 
performed as nationwide matched cohort studies and the study sample consisted of 
the PNES cohort established in Study Ⅰ, and two matched comparison groups of 
children and adolescents with epilepsy and healthy controls. Study Ⅱ described the 
occurrence of psychiatric disorders prior to and during the 2 years following the PNES 
diagnosis and reported the relative risk of psychiatric disorders as compared to data 
obtained from the two control groups. Study Ⅲ described somatic and psychiatric 
hospital service use in the PNES cohort during a 2-year period before and a 2-year 
period after the PNES diagnosis as compared to data in the epilepsy control group and 
the healthy control group. Incidence rates of inpatient admissions, outpatient care and 
emergency room visits were reported, and the number of inpatient bed days, outpatient 
visits and emergency room visits was presented.  
 
Results 
A total of 386 children and adolescents were included in the PNES cohort between 
1996 and 2014. Study Ⅰ demonstrated markedly increasing incidence rates of 
paediatric-onset PNES during the study period from 1996 to 2014. The highest 
incidence rate was observed for 16-year-old females, and comorbid epileptic seizures 
were present in more than every tenth patient. Differences between PNES with and 
without comorbid epilepsy were demonstrated, showing a higher occurrence of 
intellectual disabilities and support in school as well as prolonged time to PNES 
diagnosis in children and adolescents with comorbid epilepsy. Study Ⅱ found that 
compared with matched children and adolescents with epilepsy and healthy controls, 
children and adolescents with PNES had an increased risk of psychiatric disorders 
both prior to and in the 2 years following their PNES diagnosis. Childhood-onset 
PNES were found to be associated with a wide spectrum of different psychiatric 
disorders. Study Ⅲ demonstrated an elevated use of hospital services in the 2 years 
before and 2 years after the PNES diagnosis, as compared to both children and 
adolescents with epilepsy as well as healthy controls. Among hospital services used, 
the majority were provided by somatic hospitals, and the main part of children and 




The present PhD project is the first study to establish a nationwide validated cohort of 
children and adolescents with PNES. The findings demonstrate rising incidence rates 
and high morbidity, in terms of psychiatric disorders and primarily somatic hospital 
service use, in children and adolescents with PNES. The results highlight a need for 
planning systematic healthcare pathways with multidisciplinary treatment options to 







Psykogene ikke-epileptiske anfald, også benævnt PNES eller funktionelle anfald, er 
en lidelse, som bør overvejes, når man vurderer børn og unge med anfaldsfænomener. 
PNES defineres som en funktionel neurologisk lidelse med anfaldsvise symptomer, 
der kan minde om epileptiske anfald, men hvor anfaldene ikke skyldes epilepsi eller 
anden kendt veldefineret fysisk sygdom. PNES ses hyppigt på børneafdelinger, hvor 
omkring 10% af børn og unge, som undersøges med mistanke om epilepsi, viser sig 
at have PNES. Det kan være yderst vanskeligt at skelne mellem PNES og epilepsi, og 
den diagnostiske proces kan derfor være en udfordring. Dette kan forsinke den 
korrekte PNES-diagnose samt føre til unødvendige medicinske undersøgelser og 
fejlbehandling med epilepsi-medicin. Det beskrives ofte, at patienterne bliver overset 
og ikke modtager relevant behandling, hvilket medfører følelsesmæssig belastning for 
patienterne og deres familie samt et generelt nedsat funktionsniveau med skolefravær 
og social tilbagetrækning hos barnet eller den unge.  
Til trods for disse udfordringer er den eksisterende viden om PNES hos børn og unge 
begrænset, da langt størstedelen af tidligere studier af PNES enten har inkluderet små 
grupper af børn og unge fra højt specialiserede klinikker eller har undersøgt PNES 
hos voksne personer. 
 
Formål 
Det overordnede formål med dette ph.d.-projekt var at benytte de danske 
patientregistre til at etablere en stor landsdækkende kohorte af børn og unge med 
PNES, og på den baggrund opnå viden om sygdommens forekomst, kliniske 
karakteristika og sygelighed hos børn og unge. De tre artikler i afhandlingen havde 
følgende specifikke formål: 
1) At etablere en kohorte af børn og unge med PNES med henblik på at beskrive 
forekomsten og de kliniske karakteristika forbundet med PNES, samt undersøge om 
der ses forskelle i kliniske karakteristika hos børn og unge, som både har PNES og 
epileptiske anfald. (Studie Ⅰ) 
2) At undersøge forekomsten af og risikoen for psykiatriske sygdomme hos børn og 
unge med PNES henholdsvis før og to år efter PNES-diagnosen blev stillet 
sammenlignet med børn og unge med epilepsi samt børn og unge uden PNES eller 
epilepsi (benævnt raske kontroller). (Studie Ⅱ) 
3) At beskrive forbruget af somatiske og psykiatriske hospitalskontakter hos børn og 
unge med PNES henholdsvis to år før og to år efter PNES-diagnosen blev stillet 
sammenlignet med børn og unge med epilepsi og raske kontroller. (Studie Ⅲ). 
 
Metode 
Ph.d.-projektet er baseret på data fra danske landsdækkende patientregistre samt data 
fra patientjournaler. Studie Ⅰ var et landsdækkende kohortestudie af 5-17-årige børn 
og unge, som var registreret med en ICD-10 diagnosekode for PNES (dvs. F44.5 
”Dissociative kramper” og/eller R56.8G ”Andre og ikke specificerede kramper, Non-
epileptiske anfald”) i studieperioden 1996 til 2014. Patientjournalen for hver enkelt 
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studiedeltager blev gennemgået med henblik på at validere PNES-diagnosen. Data 
vedrørende kliniske karakteristika blev endvidere udtrukket fra patientjournalerne. 
Studie Ⅱ og studie Ⅲ blev udført som landsdækkende retrospektive matchede 
kohortestudier. Studiedeltagerne bestod af PNES kohorten fra studie Ⅰ samt to 
matchede kontrolgrupper af henholdsvis børn og unge med epilepsi og raske 
kontroller. Studie Ⅱ beskrev forekomsten af psykiatriske sygdomme før og to år efter, 
at PNES-diagnosen blev stillet samt den relative risiko for psykiatrisk sygdom 
sammenlignet med de to kontrolgrupper. Studie Ⅲ beskrev forbruget af somatiske og 
psykiatriske hospitalskontakter to år før og to år efter, at PNES-diagnosen blev stillet 
sammenlignet med de to kontrolgrupper. Incidensrater for nyopstartede indlæggelser, 
ambulante forløb og skadestuekontakter blev rapporteret, og det årlige forbrug af 
sengedage, ambulante besøg og skadestuekontakter blev beskrevet. 
 
Resultater 
Der blev i alt inkluderet 386 børn og unge i PNES-kohorten. Studie Ⅰ viste en markant 
stigende forekomst af børn og unge, som hvert år blev diagnosticeret med PNES i 
Danmark svarende til mere end en tidobling i perioden 1996 til 2014. Den højeste 
forekomst blev observeret for 16-årige piger. Epileptiske anfald blev påvist hos flere 
end hver tiende patient med PNES. De børn og unge, som både havde PNES og 
epilepsi, havde højere forekomst af intellektuelle vanskeligheder og iværksat støtte i 
skolen samt øget forsinkelse af korrekt diagnose sammenlignet med de børn og unge 
med PNES, som ikke havde epileptiske anfald. Studie Ⅱ viste, at sammenlignet med 
de to kontrolgrupper havde børn og unge med PNES en større risiko for psykiatriske 
sygdomme både før og to år efter, at PNES-diagnosen blev stillet. PNES hos børn og 
unge var forbundet med et bredt spektrum af forskellige psykiatriske sygdomme. 
Studie Ⅲ fandt, at sammenlignet med de to kontrolgrupper havde børn og unge med 
PNES et større forbrug af kontakter i hospitalsregi i de to år før samt to efter, at PNES-
diagnosen blev stillet. Hospitalskontakterne foregik primært på somatiske 
hospitalsafdelinger, og størstedelen af børn og unge med PNES havde ikke 




Dette ph.d.-projekt er det første i verden, der har etableret en landsdækkende valideret 
kohorte af børn og unge med PNES. Resultaterne viser en stigende forekomst af børn 
og unge, som diagnosticeres med PNES, samt at PNES hos børn og unge er forbundet 
med en øget sygelighed i form af psykiatrisk sygdom og primært somatiske 
hospitalskontakter både før og efter PNES-diagnosen. Samlet set understreger dette 
vigtigheden af at etablere udrednings- og behandlingstilbud i tæt samarbejde mellem 
de somatiske og psykiatriske afdelinger med henblik på at sikre en integreret 
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ADD attention deficit disorder 
ADHD attention deficit hyperactivity disorder 
ASD  autism spectrum disorder 
AED  antiepileptic drug 
CBT  cognitive behavioural treatment 
CD  conduct disorder 
CI  confidence interval 
CRF  case report form 
CRS  the civil registration system 
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DNPR the Danish national patient register 
DPCRR the Danish psychiatric central research register 
DSM diagnostic and statistical manual 
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ER  emergency room 
ES  epilepsy control group 
FND  functional neurological disorder 
HC  healthy control group 
ICD  international classification of diseases 
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My first encounter with psychogenic nonepileptic seizures (PNES) took place several 
years ago, when I was working as a junior doctor at a child and adolescent psychiatric 
department. I had two teenage girls referred around the same time for assessment of 
mood disorder symptoms. Both girls also suffered from PNES, but besides being 
teenage girls and having a diagnosis of PNES, they had very little in common. When 
assessing their biological, psychological and social characteristics, I found almost no 
similarities. I was puzzled about the aetiology of PNES based on these two very 
different profiles, and I began wondering if there was a link between PNES and the 
two girls’ psychiatric features. I asked my senior colleagues about PNES, but no one 
had much knowledge about the disorder, and when searching the scientific literature, 
I found that most prior knowledge was based on studies conducted with adult 
populations or small samples of children. 
After having assessed the two girls, I treated both of them for different psychiatric 
disorders. Along the way, I became more and more intrigued by these psychogenic 
nonepileptic seizures, which produced massive physical symptoms but had no well-
defined medical somatic explanation. During medical school, my curriculum gave me 
only little insight into functional somatic symptoms, and it puzzled me to experience 
that the brain and the body could interact in ways not yet medically explained.  
I got inspired to do research on childhood-onset PNES, when encountering my 
supervisor Charlotte Ulrikka Rask at a course on functional disorders in children and 
adolescents. Together with René Ernst Nielsen and Jakob Christensen, we set out to 
do a research project based on the establishment of a Danish nationwide cohort of 
children and adolescents with PNES. My PhD project was launched; its aim being to 
gain knowledge on the incidence, characteristics and morbidity of childhood PNES. 
With this knowledge, we aimed to establish a comprehensive clinical profile of 
children and adolescents with PNES, which could hopefully inform future strategies 
for management of this challenging disorder. 
Alongside my PhD project, I have been part of a project funded by Trygfonden aimed 
at developing patient information material for children and adolescents with PNES as 
well as their families and health professionals. As part of this project I have 
interviewed patients and their families on their experiences of living with PNES. 
These families describe to be stigmatized, being left in a treatment gap and great lack 
of relevant treatment. With the knowledge gained in this PhD project and by use of 
the material developed as part of the Trygfonden project, I hope to increase awareness 
of PNES and to help bridge the gap between the somatic and psychiatric field 
regarding this disorder. My hope for the future is to continue doing research in this 
area and to be able to do so while occupying a clinical position, where I can use my 










Psychogenic nonepileptic seizures (PNES), also known as functional seizures, are 
defined as a functional neurological disorder. This chapter will begin with a brief 
introduction to the concept of functional somatic symptoms and functional disorders 
in children and adolescents, which will be followed by a more detailed introduction 
to PNES. A literature review was conducted in order to assess the existing literature 
on children and adolescents with PNES. The search was performed in three databases 
and details of the search strategy are described in Appendix A. The literature search 
overall identified a small number of studies on children and adolescents with PNES. 
Although the number of studies published on childhood-onset PNES has increased 
over the past 20 years, many topics related to PNES are covered in detail only in the 
scientific literature on the adult population with PNES. Reference will be made to the 
scientific literature describing knowledge on PNES in the adult population when 
relevant. 
 
1.1. FUNCTIONAL SOMATIC SYMPTOMS 
Functional somatic symptoms are defined as physical symptoms that are not fully 
explained by a well-defined somatic disorder or organic pathology.1,2 Terms like 
medically unexplained symptoms (MUS) and somatoform symptoms have also been 
used to describe functional somatic symptoms. Symptoms span a spectrum of severity 
from everyday transient bodily sensations to recurring somatic symptoms, to 
conditions with chronic and debilitating symptoms defined as functional disorders.1 
Functional disorders can present with many different physical symptoms from all 
organ body systems, including pain (typically in the form of abdominal pain in 
children, or for example headache or musculoskeletal pain), fatigue, dizziness, or 
symptoms mimicking neurological disorders with motor and sensory disturbances.1 
Examples of functional disorders include conditions such as fibromyalgia, chronic 
pain, irritable bowel syndrome and PNES.  
Functional somatic symptoms are commonly encountered among children and 
adolescents and are reported to be present from early childhood.3 The Danish National 
Institute of Public Health conducted a survey on self-reported health among 11-15-
year-old school children in Denmark, reporting that daily physical symptoms were 
experienced by around 20% of boys and 30% of girls in 2018.4 The occurrence of 
persistent and impairing functional disorders in children and adolescents is not clearly 
defined as numbers vary depending on the criteria and definitions used to define the 
disorders; however, studies suggest a prevalence of around 4-10%.2,5–7 Furthermore, 
an increase in youth presenting with unspecific somatic symptoms in the hospital-
based healthcare setting has been reported,8 which could indicate a growing 




1.2. PSYCHOGENIC NONEPILEPTIC SEIZURES (PNES) 
 DEFINITION AND DIAGNOSTIC CLASSIFICATION 
Paroxysmal disorders in children and adolescents are commonly divided into epileptic 
and nonepileptic seizures (NES). Examples of NES are conditions as syncope, 
migraine, night terrors, motor tics or PNES.9 PNES  are defined as sudden and 
transient changes of movement, sensation or level of consciousness that can mimic 
epilepsy, but without any associated ictal electrical discharges in the brain.10 
Regarding the diagnostic classification of PNES, divergence is found in the 
international diagnostic classification systems. The International Classification of 
Diseases, Tenth Revision (WHO ICD-10)11 does not list PNES under a single 
diagnosis. PNES can be classified in the ICD-10 under F44.5 ”Dissociative seizures” 
or under R56.8 ”Other and Unspecified Convulsions”; however, a lack of consensus 
is reported among clinicians and a range of other ICD-10 codes has also been used by 
clinicians over time when diagnosing PNES.12 The ICD-10 diagnosis of F44.5 
“Dissociative seizures” specifies the semiology as convulsions only and with the 
existence of a presumed psychological aetiology being part of the criteria. In the 
forthcoming International Classification of Diseases, 11th Revision (ICD-11)13, 
PNES are classified as “6B60.4 Dissociative neurological symptom disorder, with 
non-epileptic seizures”, and placed alongside the additional functional neurological 
symptoms in the category of “Dissociative disorders”, and separated from the other 
functional somatic symptoms, which are placed in a category termed “Disorders of 
Bodily Distress or Bodily Experience”. The diagnostic criteria for “6B60.4 
Dissociative neurological symptom disorder, with non-epileptic seizures” are based 
on the absence of consistency with other neurological or psychiatric conditions, and 
having a prior psychological stressor is no longer a criterion.14 Thus, the ICD-11 
classifies PNES as a diagnosis of exclusion based on lack of consistency with a 
medical condition. In contrast, the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5)15 classifies PNES under the umbrella category of “Somatic 
Symptom and Related Disorders (SSRD)” as a “Conversion Disorder (Functional 
Neurological Symptom Disorder)” focusing on the presence of clinical neurological 
semiology findings typical of the disorder, whereas previous DSM-Ⅳ criteria also 
required the presence of a preceding psychological stressor.16 It appears that the new 
diagnostic classifications in both the ICD and DSM are moving away from diagnostic 
criteria based on conversion theories to a classification based on the neurological 
presentation of symptoms; still, differences exist regarding whether to lump together 
or separate PNES from other functional somatic symptom disorders.17,18 
 
 TERMINOLOGY 
Many different names have been used to describe PNES over the years, and the 




framework underlying PNES. PNES were first described in the medical literature by 
Jean-Martin Charcot (1825-1893) as hysterical seizures, and Sigmund Freud (1856-
1939) later defined the aetiology as a manifestation of experienced psychological 
trauma, which were converted into seizure-mimicking symptoms.19–21 Thus, terms 
like ”pseudoseizures”, ”hysterical seizures” and ”hystero-epilepsy” have been used to 
describe PNES based on this purely psychogenic framework. In recent decades, a 
modern conceptual framework has been introduced that integrates the mind and the 
brain and sees it as a holistic framework,22 with PNES explained by an interaction 
between biological, psychological and socioenvironmental factors.23 Advances in 
clinical neuroscience now focus on the neurobiology of PNES, and this is also 
reflected in the terminology of PNES.24 The terms “non-epileptic attack disorder 
(NEAD)” and “functional seizures” have been introduced to better integrate 
neurobiological factors without forcing an aetiological framework.25 Attention to the 
stigma associated with the terminology of PNES has been growing, and feelings of 
being misunderstood and blamed for having seizures have been described by patients 
and their families.25–27 Among parents of children with PNES, a preference for the 
terms ”functional seizures”, ”nonepileptic events” or “NEAD” has been reported,26 as 
these terms were considered the least offensive ones. The most offensive labels were 
“it is all in his or her head”, “hysterical seizures” and “psychogenic seizures”26, and 
other studies have shown that patients and their families were left with feelings of 
abandonment and not being believed by clinicians, when receiving the diagnosis of 
PNES.28–30  
The term PNES is used throughout this thesis because it is a commonly used and 
acknowledged term in research. Still, as outlined above, it is important to 
acknowledge that using the term PNES may be problematic, when communicating the 
diagnosis of PNES. The label “psychogenic” may be perceived as indicating a 
statement of a purely psychological framework underlying PNES, and it should be 
considered carefully which term to use when communicating with patients and lay 
people.  
 DIAGNOSTIC ASSESSMENT 
Identifying PNES in the clinical setting is challenged by difficulty in differentiating 
PNES from other paroxysmal events. Misdiagnosis and diagnostic delay lasting 
several years are often reported,31,32 potentially leading to inappropriate treatment  and 
iatrogenic harm.33,34 Consensus regarding the clinical requirements for a diagnosis of 
PNES to be stablished has been lacking; therefore, in 2013, an international consensus 
group of clinical experts and researchers (the International League Against Epilepsy, 
ILAE, Nonepileptic Seizures Task Force) published a report describing the minimum 
requirement for a diagnosis of PNES based on a staged approach to the diagnosis.35 
The gold standard for a PNES diagnosis is an ictal video electroencephalography 
(EEG); however, meeting the gold standard may not be possible due to lack of video 
EEG availability in the clinic or because patients primarily have seizures outside the 




epileptic seizures, and some epileptic seizures may manifest without showing 
abnormal ictal EEG activity.36 The test result of a video EEG examination cannot 
stand alone and should be viewed in the context of the patient history and semiological 
manifestations as outlined in the ILAE criteria for a diagnosis of PNES.35  






Witnessed event EEG information 
Possible Yes By witness or self-
report/description 
No epileptiform activity in routine 
or sleep-deprived interictal EEG 
Probable Yes By clinician who reviewed 
video recording or in person, 
showing semiology typical of 
PNES 
 
No epileptiform activity in routine 
or sleep-deprived interictal EEG 
Clinically 
established 
Yes By clinician experienced in 
diagnosis of seizure disorders 
(on video or in person), 
showing semiology typical of 
PNES, while not on EEG 
No epileptiform activity in routine 
or ambulatory ictal EEG during a 
typical ictus/event in which the 
semiology would make ictal 
epileptiform EEG activity 
expectable during equivalent 
epileptic seizures 
 
Documented Yes By clinician experienced in 
diagnosis of seizure disorders, 
showing semiology typical of 
PNES, while on video EEG 
No epileptiform activity 
immediately before, during or 
after ictus captured on ictal video 
EEG with typical PNES 
semiology 
 
a LaFrance WCJ, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis 
of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against 
Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54:2005-2018. The table is reproduced with 
permission from John Wiley and Sons (© 2013 International League Against Epilepsy). 
 
The ILAE diagnostic approach includes patient history, descriptions of seizure 
semiology and EEG testing, and four levels of certainty are defined based on this 
information (possible, probable, clinically established and documented PNES)35 
(Table 1). The four levels of diagnostic certainty make it possible to diagnose PNES 
without having an available ictal video EEG test result, and the levels can be used 
both when communicating the diagnosis to patients and when conducting research. 
The ILAE criteria are outlined based on evidence gathered from studies on adult 
populations,35 and it is important to notice that differences may exist regarding 
children and adolescents with PNES.37 The PNES diagnosis may be more challenging 
to establish in children and adolescents due to higher rates of comorbid epilepsy as 
well as differences in PNES semiology with more non-motor manifestations in 
children than in adults.38,39 A future consensus report on the criteria for a diagnosis of 




applied while taking into account the possible differences between the paediatric and 
adult population.  
 EPIDEMIOLOGY OF PNES 
PNES should be considered when evaluating children and adolescents with 
paroxysmal events, as around 10% of children and adolescents encountered in 
specialized epilepsy-monitoring units present with PNES.40–42 Regarding studies of 
PNES in the adult population, even higher numbers are reported with a prevalence of 
up to 20-40% in specialized epilepsy-monitoring units.43,44 Only one study has 
reported the prevalence of PNES in the general population.45 The authors proposed a 
prevalence of PNES based on a calculation using the prevalence of epilepsy and the 
assumed prevalence of PNES in patients referred to epilepsy centres, reporting an 
estimated prevalence of 2 to 33 per 100,000 persons.45 Likewise, the incidence of 
PNES has been reported only in a small number of studies. Three prior studies have 
reported the incidence rate of PNES in adolescents and adults, and two prior studies 
have reported the incidence rate of PNES in children. Incidence rates in children aged 
7-15 years from the UK and Australia have been reported at 0.4 to 0.5 per 100,000 
person years.46,47 A study from Iceland reported an incidence rate of 1.4 per 100,000 
person years for the age group 15-54 years, with the highest incidence rate reported 
for the age group 15-24 years at 3.4 per 100,000 person years.48 Two other studies on 
adults populations showed incidence rates ranging from 3.0 to 4.9 per 100,000 person 
years in individuals referred to epilepsy centers.49,50 Thus, population-based studies 
on the occurrence of PNES are scarce, and further studies are warranted. 
 CHARACTERISTICS AND COMORBIDITY 
PNES most commonly onset during young adulthood; still, the seizures have been 
observed to affect individuals at all ages.39,51–56 PNES are reported in children as 
young as 5 years of age,57,58 and studies have also reported onset of PNES in elderly 
people above 70 years of age.56,59,60 Most prior studies reporting age in children and 
adolescents with PNES are based on children referred to epilepsy-monitoring units 
and report a mean age ranging from around 12 to 15 years.40,57,61–65 
A female preponderance in PNES is observed, and two recent reviews have shown a 
female representation of around 70% in children and adolescents.57,66 A few studies 
have suggested that the female preponderance is primarily observed in adolescence, 
whereas a more equal gender distribution exists in younger children (below 12 years 
of age).41,65,67  
Comorbid epileptic seizures are reported in children and adolescents with paediatric-
onset PNES, and the proportion of children and adolescents with comorbid epilepsy 
varies from 12% to 44%,31,68–72 with most numbers coming from children recruited at 
specialized tertiary treatment units. 
Comorbid psychiatric disorders are reported in 16% to 100% of children and 




disorders are common;57,76 however, recent studies have suggested the presence of a 
broad range of psychiatric disorders, including neurodevelopmental disorders.64,77–81 
Attention has also been brought to learning disabilities and academic difficulties as 
possible precipitating factors of PNES in children and adolescents.57,82 The occurrence 
of psychopathology has been reported to be higher in adolescents than in children 
below 13 years of age.67 Most knowledge on psychiatric disorders in children and 
adolescents with PNES is based on small paediatric study samples from highly 
specialized treatment units or studies conducted on adult populations, and no prior 
study on children and adolescents with PNES has described the total spectrum of 
comorbid psychiatric disorders. 
 AETIOLOGY 
Whereas Charcot and Freud focused on a purely psychological aetiology, modern 
perspectives on PNES describe a complex multifactorial aetiology based on a model 
of biological, psychological and socioenvironmental factors.10,22,83,84 The aetiological 
factors are categorized into predisposing, precipitating and perpetuating factors, all 
considered to play an important role in the aetiology of PNES.21,85 Predisposing 
factors could be negative life events, female sex, functional somatic symptoms, 
learning disabilities, or traumatic brain injury. Precipitating factors or triggers could 
be traumatic events like bullying, a physical accident, and loss of a close relative or 
sudden onset of a somatic disease. Perpetuating or maintaining factors could be 
psychiatric disorders, sustained interpersonal problems, family dysfunction, illness 
beliefs, or lack of relevant academic support in school.86 (Figure 1) 
Past years have seen a strong focus on trauma history as a common precipitating 
characteristic in individuals with PNES. Studies show that adult populations with 
PNES often have a history of sexual or physical abuse.85 However, sexual and 
physical abuse appears to be less common in children and adolescents with PNES,57 
whereas school difficulties with bullying and academic difficulties, family discord 
and interpersonal conflicts are more commonly identified as precipitating factors in 
childhood-onset PNES.57,76 
A growing body of evidence suggests that neurobiological factors may predispose 
individuals to PNES, and functional neuroimaging studies show pathological findings 
in patients with PNES and other functional neurological disorders.16,24 A “software” 
and “hardware” analogy has been used as a metaphor to describe that abnormal 
neurobiological manifestations cause seizures in the context of an intact brain without 
pathological macroscopic findings; however, emerging evidence suggests that 
patients with PNES may have both a “software” and a “hardware” problem as 
structural brain abnormalities may as well be an aetiological factor.87 
Reuber et al. proposed an “Integrative Cognitive Model (ICM)” as an aetiological 
model integrating psychological and neurophysiological research;23 still, a recent 
ILAE report suggests that it may not be possible to capture the full range of PNES 




In total, PNES are described to have a very multifactorial and heterogenic aetiology, 
and it is necessary to approach the patients with an open mind and consider all possible 
aetiological factors within a bio-psycho-social framework as part of the assessment as 













a An aetiological framework demonstrating examples of predisposing, precipitating and perpetuating factors 
in context of a bio-psycho-social model in children and adolescents with PNES. Inspired by models 
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As outlined above, PNES are reported to be relatively rare; nevertheless, they impose 
a considerable burden on patients and their families, the healthcare system as well as 
the social service system.60,91,92  
Children and adolescents and their families describe a great burden of emotional 
distress associated with PNES and report feelings of confusion, uncertainty and 
hopelessness.29,93 Parents describe profound distress because they experience that 
clinicians lack knowledge and understanding of functional somatic symptoms, leading 
to lack of trust and feelings of insecurity.30 Patients with PNES often report 
uncertainty and insecurity surrounding PNES and feel being doubted by the clinicians, 
and negative experiences with healthcare professionals are common.94  
PNES is often associated with impairment of daily functioning including school 
absenteeism, reduced academic achievement and social difficulties,28,57,76 and with 
parental distress due to loss of work days and disruption of family functioning.76,93 
Reduced quality of life (QoL) has been reported in studies of adult patients with PNES 
as compared to patients with epilepsy.95 A single study on QoL in a population of 
adolescents with PNES38 reported a reduced QoL in the adolescents with PNES 
compared with adolescents without any psychiatric disorder.   
PNES have also been observed to be associated with high morbidity, which translates 
into numerous visits to doctors and emergency rooms, misdiagnosis as epilepsy 
leading to side effects from antiepileptic drugs (AEDs), and unnecessary medical 
investigations.76,96,97 The diagnostic delay is often up to 3.5 years, and misdiagnosis 
may lead to lack of relevant treatment and thereby affect the prognosis.67 Still, most 
knowledge on healthcare utilization in PNES is based on studies on adult populations, 
as studies on children and adolescents are scare. 
 TREATMENT AND PROGNOSIS 
Multidisciplinary management with close cooperation between physical and mental 
healthcare is a recommended treatment approach to PNES in children and 
adolescents.57,76 PNES is a disorder at the intersection between somatic and 
psychiatric care, and continuous involvement of a paediatrician or neurologist after 
transition to mental healthcare is described as important to help discontinue AEDs 
when relevant, continue to confirm the accuracy of the PNES diagnosis and assess 
any new physical symptoms.18,76 A combination of psychoeducation and 
psychotherapy is part of the recommended care, and it is important to communicate 
the diagnosis to patients and their families in a manner ensuring acceptance of the 
diagnosis and compliance with treatment.98 Several barriers to treatment have been 
described; one of them being clinicians’ attitudes towards the diagnosis.86,99 Lack of 
knowledge about PNES and even an attitude of the seizures being fake are reported 
among treating clinicians,99 and a barrier may also exist due to lack of clinical 
guidelines and systematic treatment pathways.86,100 Another barrier may be the 




diagnosis from an epilepsy diagnosis to a diagnosis of PNES is described as 
distressing.29 An experience of not being believed or confusion due to uncertainty 
among doctors has also been reported,28 underlining the importance of careful 
communication, when delivering the diagnosis of PNES.89,101 
Psychological treatment is suggested as an effective intervention in the treatment of 
functional somatic symptoms;102 still, limited evidence exists regarding the treatment 
of children and adolescents with PNES.76 A number of observational clinical studies 
have reported an effect of a multidisciplinary approach integrating mental healthcare 
with neurological care,103–105 showing improved outcomes with regained daily 
functioning and resumed education. A recent study was the first published randomized 
controlled trial (RCT) assessing treatment of PNES in children and adolescents; the 
study used a cognitive behaviourally based approach, showing a reduction of PNES 
frequency.106 Cognitive behavioural therapy (CBT) is the most investigated treatment 
approach in adults;16,107,108 however, a Cochrane review outlined that one single 
treatment approach could not be recommended over another based on the existing 
evidence, and further RCTs were recommended to increase evidence on the treatment 
of PNES.109,110 
Even though robust evidence on the treatment of PNES in children and adolescents is 
lacking, two recently published treatment frameworks deserves mentioning. Caplan 
and colleagues111 outlined a management approach based on short- and long-term 
treatment goals, including individual psychoeducation and psychological treatment 
with the child, and separate parenting psychoeducation sessions as well as close 
involvement of the school. Furthermore, Kozlowska and colleagues112 published an 
outline of a stress-system approach to functional somatic symptoms in children and 
adolescents and hence provided a framework for treatment based on the existing 
scientific and clinical research. Both frameworks outline the heterogeneity of children 
and adolescents with PNES and the need for individualized and flexible treatment 
plans, and they both present examples of treatment frameworks integrating physical 
and mental healthcare. 
An international consensus guideline on the diagnostic management and treatment of 
PNES in children and adolescents resting on current evidence and knowledge from 
clinical experts may improve management of children and adolescents with PNES. A 
stepped care model defining the management in primary care, the paediatric setting 
and the child and adolescent psychiatric department could clarify the multidisciplinary 
healthcare pathway and possibly bridge the treatment gap often experienced by these 
patients.1,100 The prognosis of PNES is reported to be better in children and 
adolescents than in adults113,114 which may be due to earlier recognition thereby 
avoiding symptom chronicity, reducing severe psychopathology and achieving 
greater intervention effectiveness.57 This difference between young and adult patients 
with PNES underscores the importance of establishing systematic treatment pathways 





1.3. EPILEPTIC SEIZURES IN CHILDREN AND ADOLESCENTS 
As mentioned earlier in this chapter, differentiating between epileptic seizures and 
PNES in children and adolescents can be challenging. In patients with co-existing 
PNES and epileptic seizures, this challenge can grow even bigger. Thus, paying 
attention to the different characteristics of PNES and epilepsy may be critical to the 
diagnostic process of distinguishing between these two disorders.  
A seizure is defined as a transient event characterized by excessive neuronal activity 
in the brain, and epilepsy is defined as a condition with an imbalance between 
neuronal excitation in the brain and deficient inhibition leading to a predisposition to 
recurring seizures.115 Epilepsy was traditionally diagnosed only if the child had a 
history of two unprovoked seizures with at least 24 hours between the seizures. 
However, this definition was extended by the ILAE proposing a clinical definition of 
epilepsy that opens up for establishing the diagnosis based on a single unprovoked 
seizure with a concurrent probability of recurrent seizures, or establishing the 
diagnosis based on a defined epilepsy syndrome.115,116 Epileptic seizures are divided 
into different types of seizures (generalized, focal and other types) based on their 
clinical manifestations and EEG patterns.115 Abnormal seizure activity is typically 
intermittent and self-limited, stereotyped, lasting seconds to a few minutes and 
randomly appearing as well as only rarely precipitated by specific triggers; and 
differences in the presenting semiology may help the clinician distinguish between 
PNES and epileptic seizures.36 An ictal video EEG recording can be used to assist in 
establishing a diagnosis of epilepsy; however, interictal EEG testing can be unreliable 
as up to 5% of children may have epileptiform activity on EEG without having clinical 
seizures.115 
In contrast to PNES, epilepsy has a bimodal incidence curve with the highest 
incidence occurring in infants and the elderly.36,117 The incidence of epilepsy is highest 
in the first year of life with numbers reported to reach 144 per 100,000 person years, 
after which the incidence decreases to around 50 per 100,000 person years in 
childhood and 20 per 100,000 person years in adolescents.115,117,118 The gender 
distribution is overall reported to be equally divided between boys and girls, though 
with a slightly higher representation of male gender in the age range 10-20 years.115,117 
Regarding aetiology, epilepsy is divided into a range of aetiological groups: structural, 
genetic, infectious, metabolic, immune and unknown.119 Furthermore, increasing 
evidence shows that epilepsy is associated with comorbidities such as psychiatric 
disorders and learning difficulties, and an association with somatic comorbidities has 
also been reported.119–121 Epilepsy is considered a disorder associated with high 
morbidity and mortality which burdens the healthcare system and leads to increased 
socioeconomic costs.121–123 
In summary, since no single clinical characteristic is reported to be pathognomonic of 
PNES,35,124 it is essential to be aware of presenting clinical characteristics that can 
assist the clinician in distinguishing between PNES and epilepsy to establish the 




with PNES to children and adolescents with epilepsy, and further research on the 
clinical features is needed to help clinicians differentiate between PNES and epilepsy.  
 
1.4. SUMMARY OF THE BACKGROUND 
In summary, PNES is reported to be a disorder associated with great distress for the 
affected children and adolescents and their families; moreover, it is a disorder posing 
a great challenge to the healthcare system. The above literature review shows that 
most published literature on childhood-onset PNES consists of descriptive case series, 
case reports, and a small number of case-control studies and systematic reviews. This 
is defined as an evidence level of 3 to 4,125 which corresponds to lower levels of 
research quality in the hierarchy of evidence. Moreover, most studies include small 
and highly selected patient populations from specialized tertiary care settings and do 
not include relevant control groups. Population-based data on the incidence, clinical 
characteristics and morbidity associated with PNES in children and adolescents are 
lacking. However, such data could inform the future provision of healthcare to 
children and adolescents with PNES, facilitate a thorough description of the 
presenting clinical characteristics and co-morbidity and thereby assist healthcare 
professionals in the clinical management of the disorder. 
The objective of the present PhD project was therefore to achieve an increased 
understanding of PNES in children and adolescents by utilizing the unique population-



















CHAPTER 2. AIMS OF THE THESIS 
2.1. OVERALL AIM 
The overall aim of this PhD project was to utilize the Danish nationwide patient 
registries to establish a large cohort of children and adolescents with PNES and 
thereby gain knowledge regarding incidence, characteristics and morbidity of 
childhood-onset PNES.  
 
2.2. AIMS OF STUDY I 
The aim of this study was threefold: 1) to establish a validated population-based 
nationwide cohort of children and adolescents with incident PNES included from both 
secondary and tertiary hospital settings over a period of 2 decades, utilizing data from 
Danish healthcare registries and medical records; 2) to utilize the established cohort 
of children and adolescents with PNES to investigate the incidence rate and clinical 
characteristics of childhood-onset PNES; and 3) to compare clinical characteristics of 
childhood-onset PNES in children and adolescents with and without coexisting 
epileptic seizures.   
 
2.3. AIMS OF STUDY II 
The aim of the study was to utilize the cohort of children and adolescents with PNES 
established in Study 1 to outline the spectrum of psychiatric disorders associated with 
childhood-onset PNES both prior to and 2 years after the PNES diagnosis. 
Furthermore, the study aimed to assess the risk of psychiatric disorders in children 
and adolescents with PNES compared to matched children and adolescents with 
epilepsy and matched children and adolescents with no PNES or epilepsy.  
 
2.4. AIMS OF STUDY III 
This study aimed to describe the somatic and psychiatric hospital utilization observed 
in children and adolescents with PNES 2 years before and 2 years after the diagnosis 
of PNES. The study aimed to compare the use of hospital services in children and 
adolescents with PNES to hospital service use observed in children and adolescents 











CHAPTER 3. METHODS 
The present thesis is based on three studies linked together by the cohort of children 
and adolescents with PNES established in Study Ⅰ (Figure 2). In Study Ⅱ and Study 
Ⅲ, the cohort of children and adolescents with PNES was matched to two control 
groups consisting of: 1) children and adolescents with epilepsy, and 2) children and 
adolescents with no PNES or epilepsy. Study Ⅰ used a combination of register data 
and data from medical hospital records. Study Ⅱ and Ⅲ were based on register data. 
The below sections will give a presentation of the Danish nationwide registries, which 
will be followed by an outline of the methods used in each of the three studies.  
 
Figure 2. The three studies of the thesis 
Abbreviations: ES: epilepsy; HC: healthy controls. 
 
3.1. THE DANISH NATIONWIDE REGISTRIES 
The nationwide population-based registries in Denmark offer an excellent opportunity 
to perform health-related research. At birth or when immigrating to Denmark, any 
person is assigned a ten-digit personal identification number (the Civil Person 
Registration number, CPR). Information on CPR numbers is contained in the Civil 
Registration System (CRS),126 which was established in 1968. The CRS holds 
information about nationality, sex and date of birth, as well as family relationships 
Study Ⅰ
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between children and their parents. The CPR number enables linkage of information 
from a wide range of Danish national registries holding information on healthcare and 
social services.  
Hospital-based care is publicly funded in Denmark, and register-based healthcare data 
have nationwide coverage of all inpatient, outpatient and acute hospital service use. 
A number of private hospitals in Denmark also provide somatic and psychiatric 
healthcare, and the registers contain data on patients treated at both public and private 
hospitals. Register-based healthcare data are not accessible to the public, but access 
for research can be obtained following approval from the Danish Health Authority, 
the Danish Health Data Authority, the Danish Data Protection Agency and Statistics 
Denmark.  
The Danish National Patient Register (DNPR)127,128 holds information on in- and 
outpatient somatic hospital contacts. The DNPR was created in 1977 and initially 
contained information on inpatient hospital care; information on outpatient hospital 
care and emergency room visits was added from 1995.  
The Danish Psychiatric Central Research Register (DPCRR)129 covers data on 
psychiatric inpatient hospital care from 1970; information on outpatient hospital care 
and emergency room visits was added from 1995. As from 1995, the DPCRR was 
integrated into the DNPR. 
The Danish Population Education Register (PER)130 includes data on all individuals 
attending education in Denmark. The PER records data on type of education and 
highest achieved educational level. Information on highest parental educational level 
for each individual can also be retrieved. 
 
 
3.2. STUDY I 
(This study was performed in collaboration with Charlotte U. Rask, Maria Rodrigo-
Domingo, Sofie G. Pristed, Jakob Christensen and René E. Nielsen. “Incidence rates 
and characteristics of pediatric onset psychogenic nonepileptic seizures”. Pediatric 
Research 2020; 88:796-803). 
 DESIGN AND DATA 
This study was conducted as a nationwide population-based retrospective cohort study 
of paediatric-onset PNES in Denmark during the study period 1 January, 1996 to 31 
December, 2014.131  
The study was based on data from the CRS, the DNPR, and the DPCRR as well as 
medical record data from hospital departments across Denmark. Data from the DNPR 
and the DPCRR were retrieved from the Danish Health Data Authority and utilized to 
include the study participants as described below, and medical record data were 
retrieved from the hospital departments and used to validate the diagnosis of PNES 




 STUDY SAMPLE 
The use of register diagnoses of PNES is challenged by the lack of consensus among 
clinicians regarding which ICD-10 diagnosis defines PNES.11,12 In order to identify a 
cohort of children and adolescents with incident PNES, we had to decide which 
register diagnoses to include. To determine which ICD-10 diagnoses would most 
likely represent paediatric PNES cases, we consulted a panel of neuropaediatric 
experts in Denmark. Drawing on their knowledge, we chose to identify all children 
and adolescents aged 5-17 years (both included) registered in the DNPR with a 
diagnosis of “Dissociative Seizures” (ICD-10; F44.5) or “Other and Unspecified 
Convulsions, Non-Epileptic Seizures” (ICD-10; R56.8G) during the period 1996-
2014 (both included). In Denmark, the diagnosis of Dissociative Seizures was 
introduced in 1995 when the ICD-10 was introduced, whereas the diagnosis of 
R56.8G was introduced in 2010 as a register diagnosis to cover non-epileptic seizures.  
The study participants were included at the time they were first given a F44.5 or 
R56.8G diagnosis. If they were registered with both inclusion diagnoses, they were 
included at the time they received the first F.445 diagnosis, since we expected this 
diagnosis to have the highest specificity to represent PNES cases. To ensure inclusion 
at PNES onset, we excluded participants, who prior to the study period were registered 
with other register diagnoses possibly representing PNES (ICD-8; 300, 305, 306, 307, 
308, 780 and/or ICD-10; F44.5, F91.8, F98.9, R56.8). These register diagnoses were 
chosen based on advice from a panel of Danish neuropaediatric experts and a Danish 
study on diagnostic practice of PNES in the paediatric setting.12 Participants solely 
registered with an F44.5 and/or R56.8G diagnosis at an emergency department were 
excluded to increase consistency of the medical record data as the clinical information 
was expected to be insufficient to validate the PNES diagnosis. 
We aimed to retrieve the medical record of every participant identified in the registries 
using the criteria described above. Medical record data were collected with the 
purpose of validating the diagnosis of PNES and describe baseline clinical 
characteristics. Thus, the discharging hospital department that registered the inclusion 
diagnosis was identified by using each participant’s CPR number. Medical records 
were collected from 48 hospital departments covering every region in Denmark. 
Collected information included data on medical admission, progress and discharge 
notes from the hospital contacts, and results of the following tests if conducted: EEG, 
magnetic resonance imaging (MRI) or computer tomography (CT) scans of the brain, 
electrocardiography (ECG) and blood screening results. A case report form (CRF) 
was developed in collaboration with a consultant neurologist (co-author JC), a 
consultant child and adolescent psychiatrist (co-author CUR) and an adult psychiatrist 
(co-author REN). The CRF contained a rating scale to be used when validating the 
PNES diagnosis and a data inventory of clinical variables to be obtained from the 
medical records (see Appendix B). We tested the CRF in a subsample of 50 patients 




managed using REDCap electronic data capture tools hosted at The Northern 
Denmark Region.132 
To validate each participant’s PNES diagnosis, we used an adapted version of the 
criteria for diagnostic level of certainty for PNES outlined by the ILAE.35 The ILAE 
criteria define the diagnostic level of certainty for PNES based on patient history 
characteristics, witnessed seizure semiology and EEG results. These criteria are 
considered the golden standard, when assessing a patient for a PNES diagnosis. We 
chose to adapt the ILAE criteria regarding the EEG data based on pragmatic 
considerations, since accessibility to EEG testing varied across the hospital settings 
in Denmark and differed over the study period. In our adapted rating scale, we focused 
on patient history and witnessed seizure semiology (Table 2). Presence of an ictal 
video EEG result was necessary to achieve the highest level of diagnostic certainty 
(“Documented”), whereas the three lower levels (“Clinically Established”, 
“Probable”, and “Possible – likely yes”) could be rated based on an ictal- or interictal 
EEG without epileptiform activity as well as without an EEG result (either missing 
data or not performed). This adaption of our abridged rating scale allowed a patient 
history consistent with PNES and witnessed seizure semiology consistent with PNES 
to be sufficient for a diagnosis of PNES without having an ictal EEG result available. 
Each included participant was rated according to the adapted ILAE criteria and placed 
in one of the following categories: “Documented”, “Clinically established”, 
“Probable”, “Possible – likely yes”, “Possible - likely no”, “Not PNES”, “Insufficient 
information to perform rating”. A participant was evaluated as a “Confirmed case” if 
rated: “Documented”, “Clinically established”, “Probable” or “Possible – likely yes”. 
A participant was evaluated as a “Not confirmed case” if rated: “Possible – likely no”, 
“Not PNES” or “Insufficient information to perform rating”. 
 
The rating was performed by the primary investigator (the PhD candidate, ASH), a 
medical doctor with 4 years of broad clinical experience from the somatic field and 4 
years of clinical experience from working in child and adolescent psychiatry. The 
rating process was initiated with a consensus rating between ASH and two co-raters; 
an experienced consultant child and adolescent psychiatrist (co-author CUR) and an 
experienced consultant neurologist (co-author JC). In addition, a subsample of cases 
was assessed by the two co-raters, to ensure that assessments performed by ASH were 
reliable.  
The patients were also evaluated for co-morbid epileptic seizures based on having an 
EEG showing epileptiform activity in addition to clinical information from the 
medical record confirming an epileptic disorder. A condition of PNES with co-morbid 
epileptic seizures was termed “mixed PNES”, and a condition of PNES without co-
morbid epileptic seizures was termed “pure PNES”. An assessment of whether the full 
criteria for a diagnosis of “Dissociative Seizures” (ICD-10; F44.5) and a diagnosis of 
“Conversion Disorder; Functional Neurological Symptom Disorder” (DSM-V; 





Table 2. Adapted version of the ILAE diagnostic levels of certainty for PNES 
(Hansen et al., 2020)131 
 
History: consistent with PNES (Yes/No) 
Witnessed event:  
A. By clinician experienced in diagnosis of seizure disorders, showing semiology 
typical of PNES, while on video EEG 
B. By clinician experienced in diagnosis of seizure disorders (on video or in person), 
showing semiology typical of PNES, while not on EEG 
C. By clinician who reviewed video recording or in person, showing semiology 
typical of PNES 
D. By witness or self-report/description 
EEG:  
A. No epileptiform activity immediately before, during or after ictus captured on 
ictal video EEG with typical PNES semiology 
B. No epileptiform activity in routine or ambulatory ictal EEG during a typical 
ictus/event in which the semiology would make ictal epileptiform EEG activity 
expectable during equivalent epileptic seizures. 
C. No epileptiform activity in routine or sleep-deprived interictal EEG 
 
 
Diagnostic level: History:  Witnessed event: EEG:  
Documented Yes A A 
Clinically established Yes B B, C, Not performed, Missing 
Probable Yes C B, C, Not performed, Missing 
Possible - likely yes Yes D B, C, Not performed, Missing 
Possible - likely no No D B, C, Not performed, Missing 
Not PNES No No B, C, Not performed, Missing 
Insufficient information to 
perform rating (II) 
II II II 
 
Conclusion on the case assessment: 
 
PNES case status Rated adapted diagnostic level 
Confirmed case Documented, Clinically established, Probable, 
Possible – likely yes  
Not confirmed case Possible – likely no, Not PNES, Insufficient 







Incidence rates (IRs) of PNES were defined as the annual number of individuals aged 
5-17 years (both included) with a validated PNES diagnosis according to above 
criteria divided by the annual number of individuals aged 5-17 years (both included) 
in the general population during the period 1996-2014.  
The clinical characteristics extracted by use of the CRF were defined based on a 
review of existing literature on PNES in children and adolescents.9,35,57,76 The clinical 
characteristics included: clinical examinations, hospital information, seizure 
characteristics, seizure semiology, history of illness, prior treatment, level of 
functioning, family characteristics and negative life events. Negative life events 
experienced prior to the diagnosis of PNES were identified based on selected sub-
items from the Childhood Traumatic Events Scale133 and the Adverse Childhood 
Experiences International Questionnaire (ACE-IQ)134. Details on the outcome 
measures on clinical characteristics are outlined in Appendix C. 
 STATISTICAL ANALYSES 
Initially, we conducted descriptive analyses on clinical data from the validated cases. 
Age was summarized by the median and range, and categorical variables were 
presented as frequencies and percentages. IRs were calculated based on data from 
Statistics Denmark covering the annual number of individuals between 5-17 years of 
age in the period 1996-2014 (both included). In years where the number of PNES 
cases was above 0 but below 3, the number of cases was automatically set to 3 due to 
data protection rules in Denmark. Data on seizure characteristics, seizure semiology 
and negative life events were presented in bar charts. Group comparisons were 
conducted regarding: pure PNES vs mixed PNES, age at PNES diagnosis (divided 
into “<12 years of age” and “≥12 years of age”) and sex. Chi-squared tests or 
Wilcoxon rank-sum tests were used for group comparisons.  
To assess the inter-rater reliability of the diagnostic rating a random subsample was 
drawn allowing the study to be able to detect a Cohen’s kappa-coefficient (K) of 0.7-
0.8 with a power of 80%. Based on the pilot testing of 50 cases performed by ASH, 
the raters were assumed to identify cases as positive for PNES in minimum 50% of 
the cases. To reject the null hypothesis (K=0.4) with a significance level of 0.05, 9-22 
patients would be needed.135 Thus, two random subsamples of 30 cases were assessed 
for the inter-rater agreement having the two co-raters assess 30 cases each. Inter-rater 
reliability was assessed with un-weighted kappas as to whether the raters evaluated 
the case “Confirmed” or “Not confirmed”.136 The un-weighted kappa coefficients 
were calculated between the primary rater and the two co-raters separately.  






The study was approved by the Danish Data Protection Agency, the Danish Health 
Data Authority and the Danish Health Authority. Patient consent was not required 
according to Danish law. The head of each clinical hospital department gave 
permission to retrieve medical record data. 
 
3.3. STUDY II 
(This study was performed in collaboration with Charlotte U. Rask, Ann-Eva 
Christensen, Maria Rodrigo-Domingo, Jakob Christensen and René E. Nielsen. 
Article submitted). 
 DESIGN AND DATA 
Study Ⅱ was conducted as a nationwide population-based retrospective matched 
cohort study of psychiatric comorbidity in children and adolescents with PNES. The 
Danish PNES cohort established in Study Ⅰ during the inclusion period between 1 
January, 1996 and 31 December, 2014 was matched with two comparison groups: 1) 
a group of children and adolescents with epilepsy (ES), and 2) a group of children and 
adolescents with no PNES or epilepsy (termed healthy controls, HC).137  
The study was based on data from four Danish registries: the CRS, the DNPR, the 
DPCRR and the PER. The CPR numbers of the individuals in the PNES cohort were 
uploaded to Statistics Denmark, and linked to the Danish nationwide register data.137   
 
 STUDY SAMPLE 
The validated PNES cohort established in Study Ⅰ defined the PNES study participants 
in Study Ⅱ, and we included every individual from the PNES cohort for whom register 
data were available. For further details on the establishment of the PNES cohort, see 
the detailed description above under the methods section of Study Ⅰ. For each 
individual in the PNES cohort, we used the CRS, the DNPR and the DPCRR to 
identify two matched comparison groups as described in the following sections. The 
sampling of the two comparison groups was done without replacement; thus 
individuals in each comparison group could not act as a comparison subject to more 
than one PNES case. 
We included a comparison group consisting of children and adolescents registered 
with a diagnosis of epilepsy (ICD-10: G40.x) during the inclusion period matched 3:1 
to the PNES cases on sex, year of birth and year of inclusion diagnosis. The index 




inclusion diagnosis of epilepsy. To ensure that we included only incident cases with 
epilepsy, children and adolescents with a diagnosis of epilepsy (ICD-8: 345; ICD-10: 
G40.x) prior to the inclusion period were excluded. Furthermore, individuals with a 
diagnosis of PNES (ICD-8: 300, 305, 306, 307; ICD-10: F44.5, R56.8G) prior to their 
index date were also excluded from the epilepsy controls. 
The healthy controls were children and adolescents from the general population 
matched 5:1 to the PNES cases on sex and year of birth. Individuals with a diagnosis 
of PNES (ICD-8: 300, 305, 306, 307; ICD-10: F44.5, R56.8G) and/or a diagnosis of 
epilepsy (ICD-8: 345; ICD-10: G40.x) prior to the corresponding index date of the 
matched PNES case were not eligible for inclusion in the HC group. 
 OUTCOMES 
Psychiatric diagnoses registered prior to the index date were grouped into diagnostic 
categories as described below and named “prevalent psychiatric disorders”. 
Psychiatric diagnoses registered within 2 years after the index date were grouped 
similarly and named “incident psychiatric disorders” when the individual had no 
registered prevalent psychiatric disorder within the diagnostic category. Individuals 
with multiple psychiatric disorders were included in the analyses of each 
corresponding diagnostic category.137  
Based on previous studies in PNES,57,76,88,138 we categorised the registered psychiatric 
diagnoses in as follows: ”Emotional disorders” (i.e. anxiety, obsessive-compulsive 
disorder (OCD) and mood disorders (ICD-10: F30-F39, F40-F42, F93, F98 (excluding 
F98.8C))), “Adjustment disorders” (i.e. stress-related conditions, post-traumatic stress 
disorder (PTSD) and attachment disorders (ICD-10: F43, F94)), 
“Neurodevelopmental disorders” (i.e. attention hyperactivity deficit disorder 
(ADHD/ADD), autism spectrum disorder (ASD), tics/Tourette’s syndrome and 
conduct disorder (CD) (ICD-10: F84, F88-F89, F90-F92, F95, F98.8C)), “Intellectual 
disorders” (ICD-10: F70-F79, F80-F83), “Somatic symptom and related disorders” 
(ICD-10: F44 (excluding F44.5), F45, F48), “Personality disorders” (ICD-10: F60-
F61), “Psychotic disorders” (ICD-10: F20-F29), “Eating disorders” (ICD-10: F50), 
“Self-harm” (ICD-10: X60-X84) and “Substance use” (F10-F19) (see Appendix D).137 
Two further outcomes were defined for both prevalent and incident psychiatric 
disorders: “Any psychiatric disorder” was a binary variable identifying the occurrence 
of any of the above defined psychiatric disorder categories in an individual, and “Two 
or more psychiatric disorders” was a binary variable identifying the occurrence of two 
or more of the above defined psychiatric disorder categories in an individual. 
Additionally, we investigated diagnostic subgroups for two diagnostic categories: 
emotional disorders (i.e. anxiety disorders, mood disorders, and OCD) and 
neurodevelopmental disorders (i.e. ADHD/ADD, ASD, CD and tics/Tourettes 




The following covariates were defined: 
“Any prevalent psychiatric disorder” was defined as a binary variable determined by 
the prevalence of “Any psychiatric disorder” prior to the index date as defined above. 
 “Parental history of psychiatric disorders” was defined as a binary variable 
determined by registration of “Any psychiatric disorder” prior to the index date in 
either of the parents of the included children and adolescents. “Parents’ highest level 
of education” was defined as the highest registered completed level of education at 
the index date for either of the individual’s parents and divided into four levels: 
primary (elementary school), secondary (high school), vocational (skilled) and college 
(short-, medium- and long-term education).137 
 STATISTICAL ANALYSES 
Continuous variables were summarized by median and interquartile range, while 
categorical variables were presented as frequencies and percentages. For each of the 
outcomes listed above, Poisson regression with robust estimation of standard error 
was used to compute relative risks (RRs) of psychiatric disorders with PNES as the 
reference group.139 We calculated both crude and adjusted RRs with corresponding 
95% CIs and reported inverted RRs and CIs for a more intuitive interpretation. For 
“Prevalent psychiatric disorders”, the models were adjusted for “Parental history of 
psychiatric disorders” and “Parents’ highest level of education”. For “Incident 
psychiatric disorders”, the models were adjusted for “Any prevalent psychiatric 
disorder”, “Parental history of psychiatric disorders” and “Parents’ highest level of 
education”. A Wald test was used for comparison of all three groups.  
Sensitivity analyses performed included sex-stratified analyses and analyses of 
subpopulations consisting of children and adolescents from the PNES population with 
1) no comorbid epileptic seizures, 2) video EEG validation of the PNES diagnosis, 
and 3) children above 12 years of age at the index date. 
Statistical analyses were performed using Stata 16 at Statistics Denmark remote 
server. Results with p-values below 0.05 were considered statistically significant. 
 ETHICS 
The Danish Data Protection Agency, the Danish Health Data Authority and the Danish 
Health Authority approved the study and data use. Patient consent was not required 
according to Danish law.  
 
3.4. STUDY III 
(This study was performed in collaboration with Charlotte U. Rask, Ann-Eva 




 DESIGN AND DATA 
Study Ⅲ was conducted as a nationwide population-based retrospective matched 
cohort study of hospital utilization in children and adolescents with PNES. The Danish 
PNES cohort established in Study Ⅰ during the inclusion period between 1 January, 
1996 and 31 December, 2014 was matched with two comparison groups: 1) a group 
of children and adolescents with epilepsy, and 2) a group of children and adolescents 
with no PNES or epilepsy (HCs).140  
The study was based on data from the CRS, the DNPR, and the DPCRR. Data on 
somatic hospital utilization were retrieved from the DNPR, and data on psychiatric 
hospital utilization were retrieved from the DPCRR. 140 
 STUDY SAMPLE 
The study sample included in Study Ⅲ was identical to the study sample included in 
study Ⅱ, thus consisting of the PNES cohort and a matched comparison group of 
children and adolescents with epilepsy as well as a matched comparison group of HCs. 
For further details on the establishment of the PNES cohort and the matched 
comparison groups, see the detailed description above under the methods section of 
Study Ⅰ and Study Ⅱ. 
 OUTCOMES 
As described in the methods section under Study Ⅱ, we defined an index date for each 
individual in the study sample. The index date for PNES cases and ES controls was 
defined by the date of the inclusion diagnosis (PNES or epilepsy). The index date for 
the HC group was defined by the index date of their matched PNES case. Furthermore, 
four periods were defined: 24-13 months before the index date, 12-0 months before 
the index date, 0-12 months after the index date, and 13-24 months after the index 
date.  
The primary outcome of the study was hospital utilization. Somatic and psychiatric 
use of hospital services registered 2 years before and 2 years after the index date was 
identified. Somatic hospital utilization was defined as utilization registered in the 
DNPR, and psychiatric hospital utilization was defined as utilization registered in the 
DPCRR.140 
 
The primary outcome was divided into the following subtypes of hospital service use 
for both somatic and psychiatric hospital utilization: 
“ER visits”: defined as registered emergency room (ER) hospital visits. 
“Inpatient admissions”: defined as commenced inpatient hospital admissions.  
“Inpatient bed days”: defined as the number of bed days in connection with an 
inpatient hospitalization. The number of bed days was defined as the number of days 




“Outpatient care”: defined as commenced outpatient hospital care. Additionally, 
inpatient hospital admissions, with outpatient visits registered as linked to the 
inpatient admission, was assumed to be incorrectly registered and was defined as 
outpatient care.   
“Outpatient visits”: defined as the number of visits registered in connection with 
commenced outpatient care.140 
 
Multiple inpatient hospitalizations may contribute to the number of bed days over a 
particular period, and a single inpatient hospitalization may contribute to the number 
of bed days in multiple periods, both instances depending on the date of admission 
and the date of discharge.  
Multiple courses of outpatient care may contribute to the number of outpatient visits 
in a single period, and a single course of outpatient care may contribute to the number 
of outpatient visits in multiple periods, depending in both instances on the initial date 
and the date of completion of outpatient care.140  
 STATISTICAL ANALYSES 
Characteristics of the study sample were reported with continuous variables 
summarized by median and interquartile range, and categorical variables were 
presented as frequencies and percentages. 
IRs and their corresponding 95% confidence intervals (CIs) were calculated and 
graphed at each period for each study group and for each of the following subtypes of 
commenced hospital service use: ER visits, inpatient admissions and outpatient care 
for somatic as well as psychiatric hospital utilization. Estimations were carried out 
using a Poisson regression model with robust standard error and an interaction term 
between time period and study group, while accounting for censoring due to death or 
immigration, and with the PNES group at 12-0 months before the index date as 
reference.139 Incidence rate ratios (IRRs), comparing the PNES group to the ES and 
HC groups, respectively, were calculated for each period based on the aforementioned 
model and reported as inverted IRRs for readability. A Wald test was used for 
comparison of all groups for each period. 
The number of ER visits, inpatient bed days, and outpatient visits for somatic as well 
as psychiatric hospital utilization were categorized and visualized as bar graphs for 
each period and study group. 
Sensitivity analyses were performed excluding the following individuals from the 
PNES population as well as their matched controls: Ⅰ) children and adolescents with 
comorbid epileptic seizures, and Ⅱ) children and adolescents not having a video EEG 
validated PNES diagnosis. An additional sensitivity analysis was performed 
excluding the inpatient hospital admissions registered with outpatient visits, assumed 
to be incorrectly registered outpatient care. 
The level of significance was set to 0.05. Statistical analyses were performed using 






The Danish Data Protection Agency, the Danish Health Data Authority and the Danish 
Health Authority approved the study and data use. According to Danish law, patient 











CHAPTER 4. RESULTS 
The main results of Study Ⅰ, Study Ⅱ and Study Ⅲ are presented in this chapter. The 
results are reported as summaries of the findings divided into main themes, and key 
figures and tables are included from the three articles on which the thesis is based. 
When relevant, additional details are provided to elaborate on the results reported in 
the articles. 
 
4.1. STUDY I 
(This study was performed in collaboration with Charlotte U. Rask, Maria Rodrigo-
Domingo, Sofie G. Pristed, Jakob Christensen and René E. Nielsen. “Incidence rates 
and characteristics of pediatric onset psychogenic nonepileptic seizures”. Pediatric 
Research 2020; 88:796-803). 
 THE PAEDIATRIC PNES COHORT 
We identified 464 participants in the registers with one of the two inclusion diagnoses 
for PNES (ICD-10: F44.5 and/or R56.8G). After exclusion due to either a prior 
diagnosis of a possible PNES condition or registration at an emergency department 
only, 451 participants remained available for collection of medical record data. 
Medical records were retrieved for 426 participants from 46 different hospital 
departments covering every region of Denmark, with two departments not consenting 
to participate in the study. We rated 386 patients as cases and included them in the 
final PNES study cohort (Figure 3). Children and adolescents in the PNES cohort were 
recruited from peadiatric departments (45.3%), neurology departments (42.5%), child 
































• Registered with ICD-8; 300, 305, 306, 307, 
308, 780 or ICD-10; F44.5, F91.8, F98.9, 
R56.8, prior to the study period, n = 4 
• F44.5 and/or R56.8G only registered in 
relation to an emergency department contact, 
n = 9 
 
Ranked distribution: 
F44.5, n = 363 
R56.8G, n = 88 
 
Total, n = 451 
 
Medical journals retrieved: 
F44.5, n = 339 
R56.8G, n = 87 
 
Total, n = 426 
 
Excluded: 
• Medical journal no longer in archive, n = 22 
• Hospital department not responding on 
invitation to participate, n = 3 
 
PNES cohort utilized in Study Ⅰ –  
cases with a validated PNES diagnosis: 
F44.5, n = 320 
R56.8G, n = 66 
  
Total, n = 386 
 
Excluded: 
• Insufficient information to rate case status,  
n = 9 
• Evaluated to have epilepsy and not PNES,   
n = 11 
• Evaluated to have other medical disorder 
and not PNES, n = 20 
 
             Inclusion criteria: 
Registered with F44.5 and/or R56.8G 
Age at diagnosis 5-17 years (both incl.) 
Time period: 01.01.96-31.12.14 
 
Total, n = 464 
 
PNES cohort utilized in  
Study Ⅱ and Study Ⅲ: 
F44.5, n = 320 
R56.8G, n = 66 
 
Total, n = 384 
 
Excluded: 





 CASE RATING 
The inter-rater reliability was assessed utilizing two random samples of 30 cases, with 
the two co-raters rating 30 cases each. There was no significant difference between 
the sample utilized for the inter-rater reliability assessment and the total study sample  
regarding female gender (n = 48 (80.0%) vs. n = 309 (79.0%), P = .86), age at 
inclusion (15.68 vs 15.70 years, P = .80), year of diagnosis (June 2011 vs September 
2011, P = .87) or frequency of ICD-10 F44.5 as inclusion diagnosis (n = 51 (85.0%) 
vs. n = 312 (79.8%), P = .34). There was agreement between the primary rater and the 
two co-raters in 100% (rater CUR; Cohen’s kappa = 1.0) and 93.3% (rater JC; Cohen’s 
kappa = 0.76) of classifications of participants as PNES cases. This corresponds to an 
agreement level of almost perfect (Cohen’s kappa range: 0.81-1.0) and substantial 
(Cohen’s kappa range: 0.61-0.80). The rated diagnostic levels for the final PNES 
cohort were: “Documented”: n = 90 (23.3%), “Clinically Established”: n = 173 
(44.8%), “Probable”: n = 23 (6.0%) and “Possible – likely yes”: n =100 (25.9%). EEG 
information was retrieved for 336 (87.0%) of the final PNES cases.131 
 VALIDITY OF THE REGISTER DIAGNOSES 
Regarding the validity of the two inclusion register diagnoses, the positive predictive 
value (PPV) of a PNES diagnosis was 94.4% for ICD-10 F44.5 and 75.9% for ICD-
10 R56.8G. Furthermore, all cases included in the final PNES cohort fulfilled the 
diagnostic criteria for “Conversion Disorder; Functional Neurological Symptom 
Disorder” (DSM-V; 300.11), whereas only 199 (51.6%) cases in the final study cohort 
fulfilled the criteria for the diagnosis of “Dissociative Seizures” (ICD-10; F44.5). This 
was primarily due to cases not fulfilling one of the specific criteria of ICD-10 F44.5 
regarding a prior history of a stressful life event (n = 164, 42.5%).131  
 INCIDENCE RATES OF PAEDIATRIC-ONSET PNES 
The IR of paediatric-onset PNES in Denmark was 2.4 per 100,000 person years during 
the total study period between 1996 and 2014. However, the IR increased markedly 
between 2005 and 2014, with the maximum IR of 7.4 per 100,000 person years 
observed in 2014 (Figure 4). The increase during the study period was observed 
primarily in females, who presented an IR of 12.0 per 100,000 person years in 2014, 
while the male IR was 3.1 per 100,000 person years. Regarding the IR for the total 
study period stratified by age at diagnosis, the highest IR was observed for the 16-
year-old adolescents with an IR of 7.9 per 100,000 person years (Figure 5).  For the 
IRs stratified by rated diagnostic level of certainty for PNES, the “Clinically 
established” PNES cases showed the highest IR with a maximum of 2.7 per 100,000 
person years in 2014, followed by an IR of 2.1 per 100,000 person years in the 
“Possible – likely yes” cases, an IR of 1.8 per 100,000 person years in the 





Figure 4. Annual incidence rates of paediatric-onset PNES in Denmark during 
the period 1996-2014 (Hansen et al.,2020)131  
  
 
Figure 5. Incidence rates of paediatric-onset PNES based on age at diagnosis in 





 CLINICAL CHARACTERISTICS 
In the PNES cohort, most of the children and adolescents were females (83.4%) with 
a median age at diagnosis of 15.7 years. The preponderance of females was lower 
among children below 12 years of age than among children ≥12 years of age (70.3% 
vs. 84.8%, P = .02). A comorbid condition of epilepsy (i.e. mixed PNES) was 
confirmed in 55 (14.2%) of the validated PNES cases.131   
A prior history of psychiatric disorders was reported in 78 patients (20.2%) and 62 
(16.1%) had a history of self-harm behavior. In total, 210 patients (54.4%) reported 
having experienced a negative life event. In the pure PNES group, school bullying 
and interpersonal conflicts were the most often reported events, while child neglect 
and stressful parental divorce were the most common events in the mixed PNES 
group; still, only the difference in child neglect was statistically significantly different 
(4.5% vs 14.6%, P = .004).131  
Regarding level of functioning, school problems were reported in 133 (34.5%). A total 
of 105 participants (27.2%) had established support in school, 31 (8.0%) had an 
intelligence quotient (IQ) below 70 (i.e. mental retardation) and 94 (24.4%) had 
specific learning difficulties. The mixed PNES group showed a statistically 
significantly higher proportion of both intellectual disabilities and support in school.  
Regarding seizure characteristics, the distribution of time from onset of seizures to 
PNES diagnosis was significantly different between the groups (P = .03) with the pure 
PNES group having a shorter time between onset of seizures and PNES diagnosis (0-
6 months). Still, the most common duration from onset of seizures to PNES diagnosis 
was 0-6 months in both the pure PNES group (43.5%) and mixed PNES group 
(25.9%). In persons with PNES, seizures were most often reported to happen weekly 
(pure: 61.5% vs mixed: 50.6%) and the seizures were reported to most often last 5-30 
minutes (pure: 61.2% vs mixed: 49.7%).131  
Seizure semiology was overall observed to be very similar for the pure PNES and 
mixed PNES groups. The most commonly reported seizure semiologies were having 
a seizure in the presence of others, not having seizures during sleep, having 
asynchronous movements, having seizures of long duration (i.e. lasting >5 minutes) 
and having silent seizures. However, some statistically significant differences 
appeared when we compared the pure PNES and the mixed PNES cases regarding 
seizure semiology: “Not during sleep” (pure: 258 (78.0%) vs mixed: 36 (65.5%), P < 
.05), “Silent seizures” (pure: 235 (71.0%) vs mixed: 29 (52.7%), P < .01) , “No 
incontinence/tongue biting” (pure: 195 (58.9%) vs mixed: 24 (43.6%), P < .05), 
“Emotional features” (pure: 32 (9.7%) vs mixed: 15 (27.3%), P < .001) and 
“Vocalization/ictal crying” (pure: 1 (0.3%) vs mixed: 2 (3.6%), P < .01). Furthermore, 
a lower occurrence of asynchronous movements was observed in the children below 






4.2. STUDY II 
(This study was performed in collaboration with Charlotte U. Rask, Ann-Eva 
Christensen, Maria Rodrigo-Domingo, Jakob Christensen and René E. Nielsen. 
Article submitted). 
 THE STUDY SAMPLE 
A total of 384 children and adolescents with PNES were included in this study (female 
proportion: 81.8%, median age at inclusion: 15.7 years (IQR: 14·1-16·8)) (Figure 3). 
The two matched control groups consisted of 1,152 children and adolescents with 
epilepsy and 1,920 HCs.137  
 RISK OF PSYCHIATRIC DISORDERS 
Among children and adolescents with PNES, 153 (39.8%) had a prevalent psychiatric 
disorder at the index date, and 150 (39.1%) received an incident psychiatric disorder 
diagnosis. An elevated risk of “Any psychiatric disorder” was observed in the PNES 
cases for both prevalent and incident diagnoses as compared with the ES group 
(prevalent: adjusted RR 1.87 (95% CI: 1.59-2.21), incident: adjusted  RR 2.33 (95% 
CI: 1.92-2.83)) and the HC group (prevalent: adjusted RR: 5.54 (95% CI 4.50-6.81), 
incident: adjusted RR 8.37 (95% CI: 6.31-11.11)) (Table 3).137 
 SPECTRUM OF PSYCHIATRIC DISORDERS 
In the PNES cases, prevalent psychiatric disorders consisted mostly of adjustment 
disorders (17.5%), SSRDs (12.5%), neurodevelopmental disorders (11.5%), 
emotional disorders (10.7%) and intellectual disabilities (6.8%). The most frequent 
incident disorders among PNES cases were adjustment disorders (12.5%), emotional 
disorders (9.9%), somatic symptom disorders (9.1%), and psychotic disorders (7.4%), 
followed by neurodevelopmental disorders (6.5%). Comparing the PNES cases with 
the ES group, we found the highest RRs for prevalent SSRDs (adjusted RR 9.40 (95% 
CI: 5.31-16.64)), personality disorders (adjusted RR 2.94 (95% CI: 1.17-7.36)) and 
adjustment disorders (adjusted RR 2.14 (95% CI: 1.60-2.86)); still, the PNES cases 
showed an elevated risk of nearly all psychiatric disorders categories, only exceptions 
were a lower risk of psychotic disorders (adjusted RR 0.97 (95% CI: 0.50-1.90) and 
substance use (adjusted RR 0.70 (95% CI: 0.31-1.58). The risk of all incident 
psychiatric disorders reported was higher among PNES cases than among ES cases. 
Comparing the PNES cases to the HCs, we observed higher risks for all prevalent and 






Table 3. Prevalent and incident psychiatric disorders in the PNES cohort and 
their matched epilepsy control group (ES) and healthy controls (HCs)a  
(Hansen et al., paper submitted)137 
 PNES 
(n = 384) 
ES 
(n = 1152) 
HC 












    RR, crude 
    (95% CI) 





    RR, adjusted* 
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a Data are presented as number (percentage) unless otherwise indicated. Relative risks (RRs) are presented 
with corresponding 95% CIs. RRs were calculated with the PNES group as reference and reported as 
inverted RRs and CIs for a more intuitive interpretation. 
* Adjusted for: Parental history of psychiatric disorders; Parents’ highest level of education. 
** Adjusted for: Any prevalent psychiatric disorder; Parental history of psychiatric disorders; Parents’ 
highest level of education. 
 
 
 SUBTYPES OF PSYCHIATRIC DISORDERS 
Figure 6 illustrates the distribution of subtypes of emotional disorders and 
neurodevelopmental disorders in the PNES cases and the control groups, respectively. 
Anxiety disorders and mood disorders were most common in the PNES cases when 
investigating the emotional disorders category, with anxiety disorders being the most 
prominent among incident disorders in the PNES cases. Among the 
neurodevelopmental disorders, attention deficit hyperactivity disorder (ADHD/ADD) 








Figure 6. Prevalent and incident emotional disorder subgroups and 
neurodevelopmental disorder subgroups in the PNES cohort and their matched 
epilepsy control group (ES) and matched healthy controls (HCs)  





a Each individual can be represented in more than one of the diagnostic subgroups. Due to data protection 
rules in Denmark, observations below 3 were not reported. 
Abbreviations: OCD: obsessive compulsive disorder; ADHD: attention deficit hyperactivity disorder; 





 SENSITIVITY ANALYSES 
Sensitivity analyses were conducted on PNES cases with the following 
characteristics: 1) no coexisting epilepsy (n=330), 2) a video EEG confirmed PNES 
diagnosis (n=89), and 3) age above 12 years at the index date (n=346). All sensitivity 
analyses were robust to the study findings showing comparable results regarding the 
observed occurrence of psychiatric disorders and the calculated RRs for both the 
prevalent and incident psychiatric disorders. The sex-stratified analyses showed a 
similar occurrence and distribution of psychiatric disorders among males and females 
in the PNES population, and the calculated RRs remained comparable as well.137 
 
4.3. STUDY III 
(This study was performed in collaboration with Charlotte U. Rask, Ann-Eva 
Christensen, Jakob Christensen and René E. Nielsen. Article in preparation). 
 STUDY SAMPLE 
A total of 3,456 children and adolescents (PNES cases: n = 384, ES group: n = 1,152, 
HC group: n = 1,920) were included in the study between 1 January, 1996 and 31 
December, 2014, with a median age at inclusion of 15.7 years (IQR: 14.1–16.8) and 
a female proportion of 81.8%. The PNES cases contributed with full person time in 
in each period before and after the index date, whereas minimal censoring was present 
in the ES and HC groups after the index date.140  
 HOSPITAL UTILIZATION 
In general, the PNES group had a higher level of commenced ER visits, inpatient 
admissions and outpatient care per person time than the ES and HC group in both the 
somatic and psychiatric hospital setting (Figure 7). Furthermore, a statistically 
significant difference in IRRs in each period was observed between the groups. 
Additionally, a higher number of ER visits, inpatient bed days, and outpatient visits 
was observed among the PNES cases than among the ES and HC groups for both 













Figure 7.  Incidence rates (IRs) of hospital service use in children and adolescents with PNES 
and their matched control groups, by period before and after the index datea  
(Hansen et al., paper in preparation)140 
 
a The vertical dotted line indicates the index date (i.e. date of inclusion diagnosis, or corresponding date for HCs). IRs are 
presented with corresponding 95% CIs. Due to data protection rules in Denmark, observations above 0 but below 3 were 
automatically set as “3“. 
Abbreviations: IR: incidence rate; ER: emergency room; mos.: months; PNES: psychogenic non-epileptic seizures; ES: 





 SOMATIC HOSPITAL UTILIZATION 
The highest IR of somatic hospital utilization among the PNES cases was observed 
for outpatient care in the period 0-12 months after the index date (IR = 3.05 (95%: CI 
2.76–3.35)) with a similar IR in the period 12-0 months before the index date (IR = 
2.93 (95%: CI 2.66–3.21)). The highest occurrence of somatic ER visits and inpatients 
admissions among PNES cases was observed in the period 12-0 months before the 
index date (ER visits: IR = 1.73 (95%: CI 1.43–2.03); inpatient admissions: IR = 2.50 
(95% CI: 2.18–2.83)), and the IRs were observed to decline during the 2 years after 
the index date to a level comparable to that seen in the period 24-13 months before 
the index date (ER visits: IR = 0.87 (95%: CI 0.63–1.11); inpatient admissions: IR = 
0.68 (95% CI: 0.54–0.81)) (Figure 7). As shown in Figure 8, a high number of somatic 
ER visits, bed days and outpatient visits were more common in the PNES cases than 
in the ES and HC groups.140 
 PSYCHIATRIC HOSPITAL UTILIZATION 
The IRs of psychiatric ER visits and inpatient admissions were generally lower than 
in IRs presented in the somatic setting for both PNES cases and the ES and HC groups 
across all periods (Figure 7). The IRs of psychiatric outpatient care were observed to 
increase after the index date in PNES cases with the highest IRs in the period 0-12 
months after the index date (IR = 0.54 (95%: CI 0.44–0.65)). Figure 9 outlines the 
low occurrence of psychiatric ER visits and bed days in both PNES cases and the 
matched control groups. In PNES cases, a high number of psychiatric outpatient visits 
(≥10) were most frequent in the period 0–12 months after the index date (n = 37 
(9.6%)). Among PNES cases, 61.5% had no psychiatric hospital service use in the 2 
years after the index date.140 
 SENSITIVITY ANALYSES 
We conducted sensitivity analyses excluding the following children and adolescents 
from the PNES population: Ⅰ) children and adolescents with comorbid epileptic 
seizures (n = 54), and Ⅱ) children and adolescents not having a video EEG validated 
PNES diagnosis (n = 295), as well as their matched controls. A further sensitivity 
analysis was conducted excluding all inpatient admissions with registered outpatient 
visits and assumed to be incorrectly registered outpatient care. The sensitivity 








Figure 8. Somatic ER visits, bed days and outpatient visits in children and adolescents 
with PNES and their matched control groups, by period before and after the index 
datea (Hansen et al., in preparation)140 
a The index date was defined by the date of the inclusion diagnosis (PNES or epilepsy) for the PNES and 
ES group and by the corresponding index date of the matched PNES case in the HCs. 
Abbreviations: ER: emergency room; PNES: psychogenic nonepileptic seizures; ES: epilepsy; HC: 








Figure 9. Psychiatric ER visits, bed days and outpatient visits in children and 
adolescents with PNES and their matched control groups, by period before and 
after the index datea (Hansen et al., in preparation)140 
 
a The index date was defined by the date of the inclusion diagnosis (PNES or epilepsy) for the PNES and ES 
group and by the corresponding index date of the matched PNES case in the HCs. 
Abbreviations: ER: emergency room; PNES: psychogenic nonepileptic seizures; ES: epilepsy; HC: healthy 


















CHAPTER 5. DISCUSSION  
This PhD project is the first nationwide population-based study of paediatric-onset 
PNES. A large validated cohort of children and adolescents with PNES was 
established by performing a rigorous retrospective medical chart review covering a 
period lasting 2 decades. The study included two large comparison groups consisting 
of children and adolescents with epilepsy and children and adolescents without PNES 
or epilepsy (termed healthy controls, HCs). The findings show increasing IRs of 
pediatric-onset PNES during the study period from 1996 to 2014. The highest 
incidence rate was observed for 16-year-old females, and more than every tenth child 
and adolescent with PNES had comorbid epileptic seizures. Differences between 
PNES with and without comorbid epilepsy were demonstrated, showing a higher 
occurrence of intellectual disabilities, more support in school as well as prolonged 
time to PNES diagnosis in the children and adolescents with comorbid epilepsy 
compared with those without epilepsy. We found that compared with children and 
adolescents with epilepsy and HCs, children and adolescents with PNES had an 
increased risk of psychiatric disorders both prior to their PNES diagnosis and the first 
2 years after their PNES diagnosis. Childhood-onset PNES was found to be associated 
with a wide spectrum of psychiatric disorders. Finally, the findings demonstrated that 
children and adolescents with PNES used more hospital services in the 2 years before 
and 2 years after their PNES diagnosis than children and adolescents with epilepsy 
and HCs. The main part of hospital services was provided in the somatic hospital 
setting, and somatic service use was most prevalent in the year preceding the PNES 
diagnosis. The elevated level of somatic service use persisted after the PNES 
diagnosis and remained higher than in children and adolescents with epilepsy as well 
as HCs. The majority of children and adolescents with PNES received no psychiatric 
hospital care after their PNES diagnosis.     
This chapter will discuss the findings of the three studies of the thesis. The findings 
will be summarized and discussed. This will be followed by a discussion of the 
methodological strengths and limitations of the PhD project. 
 
5.1. INCIDENCE RATES OF CHILDHOOD-ONSET PNES 
Study Ⅰ gives a population-based description of the incidence rates of pediatric-onset 
PNES.131 To the best of my knowledge, no prior study has reported the incidence rates 
of PNES in a nationwide cohort of children and adolescents with validated PNES. The 
overall IR of PNES among 5-17-year-old children and adolescents during the period 
1996-2014 in Denmark was 2.4 per 100,000 person years. A progressive increase in 
incidence rates was observed between 2005-2014 with the IR peaking in 2014 at 7.4 




the study period, females presented the highest IR in 2014 of 12.0 per 100,000 person 
years, while males showed a notably lower IR of 3.1 per 100,000 person years in the 
same year. When stratified by age at diagnosis, sixteen-year-old adolescents presented 
the highest IR for the total study period at 7.9 per 100,000 person years.131 
As outlined in the literature review of this thesis, only five prior studies have 
investigated PNES incidence rates. Two studies reported incidence rates in children 
and adolescents, and three studies investigated adolescents and adults. The two studies 
reporting on children and adolescents (7-15-year-olds) were conducted in Australia 
and the UK in the study periods 2002-2003 and 2008-2009, respectively.46,47 These 
studies reported incidence rates based on national surveillance performed by 
consultant paediatricians, as well as child and adolescent psychiatrists in the UK 
study, who were asked to report the monthly number of cases assessed with a new 
diagnosis of conversion disorder. Case definition was based on DSM-Ⅳ criteria for 
conversion disorder, and all types of conversion disorders were included. Numbers of 
children and adolescents assessed to have a non-epileptic seizure disorder were 
reported; however, the diagnostic certainty of the diagnosis cannot be evaluated as the 
clinical information on which the diagnosis rests was not outlined. Thus, the numbers 
reported depend on the diagnostic skills of each consultant. The two studies reported 
IRs ranging from 0.4-0.5 per 100,000 person years. 
The three studies reporting IRs in adolescents and adults were conducted in Iceland, 
the US and Scotland.59 The Icelandic study was performed between 1992 and 1996, 
and all patients over 15 years of age in the country having new-onset seizures were 
examined with a video EEG.48 The study found an IR of 1.4 per 100,000 person years 
for individuals aged 15-54 years. Individuals aged 15-24 years had the highest IR (3.4 
per 100,000 person years), and females had the highest IR in this age group (5.9 per 
100,000 person years). The US study from Hamilton county, Ohio, was performed as 
a retrospective study between 1995-1998 and included all individuals ≥18 years of 
age who were referred to an epilepsy specialist centre to have a video EEG 
examination.49 The study reported an IR of 3.0 per 100,000 person years, which is 
higher than the numbers reported in the Icelandic study. The final study, conducted 
between 2006 and 2008, was from Scotland and covered a population of 367,566 
individuals. Identifying all patients ≥13 years of age who had a video EEG-confirmed 
diagnosis of PNES at an epilepsy specialist clinic, the study reported an incidence at 
4.9 per 100,000 person years.50  
Comparing the findings from Study Ⅰ to the IRs reported in the previously published 
studies, the overall IR for the total study period (2.4 per 100,000 person years) was 
within the range of the previously reported IRs (0.4-4.9 per 100,000 person years). 
However, in Study Ⅰ, the IRs rose to 7.4 per 100,000 person years in 2014, thus at a 
considerably higher level than previously reported.  
When comparing the reported results, methodological differences in the studies 
should be noted as these may explain the varying IRs reported. Both the duration and 
the period varied across the studies, as did the inclusion criteria. The UK and 




methodology and may therefore underestimate IRs.46,47 Variable response rates among 
the clinicians may lead to underestimation of IRs, and individual diagnostic practices 
may vary leading to further selection bias. The three studies including adult 
populations may also underestimate IRs because they relied on diagnostic criteria 
requiring video EEG examination.48–50 Hence, a selection bias may be introduced as 
individuals may have been diagnosed with PNES at a less specialized clinic without 
access to video EEG. This could mean that less complex cases with a clear PNES 
semiology were not included in these studies, and that the IRs may represent a 
population of highly selected cases from tertiary treatment units.  
The IRs reported in Study Ⅰ of this thesis may present a more true reflection of the IRs 
of paediatric-onset PNES in the general population. Children and adolescents in the 
PNES cohort were included based on an adapted version of the ILAE criteria for 
PNES,35,131 and included cases with an ictal video EEG testing as part of the diagnostic 
management as well as cases with a PNES diagnosis primarily based on the 
assessment performed by clinicians. Thus, the PNES cohort established in the present 
PhD project was recruited from both secondary and tertiary hospital settings, which 
reduced the risk of selection bias compared with prior studies. 
 
The causal relationship underlying the rising IRs reported in Study Ⅰ cannot be 
explored based on the data available to this project. The rising IRs may represent a 
true increase in the occurrence of PNES; however, other explanations may also 
explain the increase. Hence, more knowledge of PNES among the healthcare 
professionals may improve awareness and recognition of the disorder, and hence 
contribute to increasing IRs over time. Growing consensus on the diagnostic 
management and which ICD-10 diagnosis to register when establishing the diagnosis 
of PNES may further contribute to increasing IRs as the eligible study participants in 
Study Ⅰ were identified based on register diagnoses. An increased level of precipitating 
factors such as experienced stress should also be considered as a heightened stress 
level may increase the risk of PNES among children and adolescents,141 as reflected 
in rising IRs. In total, several factors may help explain why rising IRs are observed 
among children and adolescents with PNES, and future studies should further explore 
the incidence rates of PNES. 
 
5.2. CLINICAL CHARACTERISTICS 
Study Ⅰ outlines a clinical profile of characteristics observed in the cohort of children 
and adolescents with PNES and gives a presentation of differences between PNES 
with and without comorbid epilepsy.131 A number of findings described in prior 
smaller studies were replicated in this larger study sample, and new findings were 
reported regarding differences between PNES with and without epilepsy.  The 
findings are discussed in the paper published based on study Ⅰ.131 This section will 




will be followed by a discussion of previously published literature comparing PNES 
with and without comorbid epilepsy. 
 
Study Ⅰ confirmed previous literature reporting a preponderance of females among 
children and adolescents diagnosed with PNES.57,76 The frequent presence of 
accompanying psychiatric and specific socioenvironmental issues was confirmed as 
well. Study Ⅰ also confirmed previous reports of school difficulties, learning 
difficulties and a need for school support in subjects diagnosed with PNES.76 Around 
half of children and adolescents with PNES reported having experienced prior 
negative life events the most common of which were school bullying and 
interpersonal conflicts, whereas sexual and physical abuse were less commonly 
reported as also described in prior studies of pediatric-onset PNES.36,73 The range of 
seizure semiologies and the seizure characteristics observed in the PNES cohort were 
largely similar to those previously reported, and the only differences found were a 
higher occurrence of asynchronous movement semiology and a lower frequency of 
seizures (i.e. weekly) in Study Ⅰ than in previous studies.32,39,51,61,142 
 
A total of 14.2% had comorbid epileptic seizures in the PNES cohort in Study Ⅰ, while 
prior studies have reported numbers varying from 12% to 44%.42,69,143 The higher 
numbers reported in prior studies could be due to the fact that these studies analysed 
more complex cases having study participants recruited from specialized epilepsy 
clinics, whereas the results from Study Ⅰ are more likely to reflect the true occurrence 
across a wider spectrum of PNES severity as our cases were recruited from all levels 
of hospital-based care. The findings from Study Ⅰ demonstrate that the clinical 
characteristics associated with PNES with and without comorbid epilepsy were 
largely comparable. However, some differences were also observed. Hence, children 
and adolescents with PNES and coexisting epileptic seizures experienced a longer 
delay from onset of PNES to PNES diagnosis as well as a higher occurrence of 
intellectual disabilities and support in school. Thus, comorbid epileptic seizures 
appeared to challenge the process of establishing a diagnosis of PNES as well as 
warrant an assessment of possible learning disabilities.  
The literature review performed as part of this thesis identified a small number of prior 
studies comparing pediatric-onset PNES with and without comorbid epilepsy, and all 
of the studies included small sample sizes. A UK study performed from 1987 to 1997 
included 35 patients with PNES and 11 patients with PNES and comorbid epilepsy in 
the age range 6-18 years.70 The study concluded that the prognosis of seizure 
remission was best in patients without comorbid epileptic seizures. A Danish study 
from 1997 examined nine patients with PNES and three patients with PNES and 
comorbid epilepsy in the age range 8-17 years.144 The study demonstrated that mental 
retardation was present in all cases with coexisting epileptic seizures, which is in line 
with the results from Study Ⅰ. A Brazilian study published in 2016 (i.e. information 
on the study period is not presented in the manuscript) included 32 patients with PNES 
and 21 patients with PNES and comorbid epilepsy in the age range 7-17 years.97 The 




two groups, whereas Study Ⅰ reported an increased delay in time to diagnosis in 
patients with PNES and comorbid epilepsy. The presence of comorbid epileptic 
seizures could increase the complexity of the clinical assessment, which may be 
reflected in a longer delay in time to diagnosis. On the other hand, the presence of 
comorbid epileptic seizures could also be associated with earlier diagnosis of PNES 
as patients would be expected to be in closer contact with the healthcare system.97 
Finally, a study conducted in Italy from 2018 to 2019 included 15 patients with PNES, 
seven patients with PNES and comorbid epilepsy and 12 patients with epilepsy and 
no coexisting PNES.145 All three groups were compared regarding psychopathological 
features. The study reported that patients with PNES (both with or without comorbid 
epilepsy) had higher rates of impairment reflected in the Children’s Global 
Assessment Scale (C-GAS), had a higher occurrence of mood disorders, reported 
more negative life events, and had a lower resilience than patients only having 
epileptic seizures. Similar presentations of alexithymia and emotional dysregulation 
were observed in all three groups.  
In total, prior evidence on the differences between PNES with and without comorbid 
epilepsy in children and adolescents is very limited. Regarding the adult population, 
a lack of evidence was also reported in a recent review of PNES with and without 
comorbid epilepsy.146 The review identified a total of nine studies published from 
2000 to 2015 and concluded that existing data were insufficient to reliably define 
variables associated with PNES and comorbid epilepsy.146 Thus, further research is 
needed to clarify potential factors associated with PNES with and without comorbid 
epilepsy. This knowledge may qualify the challenging diagnostic process of 
distinguishing between PNES and epilepsy and may inform the discussion whether 
having epileptic seizures may be a predisposing factor for PNES. 
 
5.3. PSYCHIATRIC COMORBIDITY  
Study Ⅱ was conducted as a nationwide matched cohort study. It showed that children 
and adolescents with PNES were at higher risk of being diagnosed with psychiatric 
disorders both prior to as well as in the 2-year period after their PNES diagnosis than 
children and adolescents with epilepsy as well as healthy controls.137 The percentage 
of children and adolescents registered with a psychiatric diagnosis before receiving 
their PNES diagnosis was 39.8%, and 39.1% were diagnosed with an incident 
psychiatric diagnosis in the 2-year period after having received the PNES diagnosis. 
The findings from Study Ⅱ demonstrated that pediatric-onset PNES was associated 
with a wide spectrum of psychiatric disorders the most common being adjustment 
disorders, SSRDs, emotional disorders and neurodevelopmental disorders.137  
When comparing the results from Study Ⅰ and Study Ⅱ, a difference is observed 
regarding the occurrence of psychiatric disorders prior to the PNES diagnosis. In 
Study Ⅰ, 20.2% had a history of psychiatric disorders at the time of PNES diagnosis 




plausible explanation for this difference could be that the data in Study Ⅰ were 
extracted from medical records that relied on information documented by the 
clinicians who assessed the children and adolescents, and there may be limitations 
regarding the completeness of the data. The majority (89.6%) of the PNES cohort 
received their PNES diagnosis at a somatic department and clinicians may have failed 
to document the prior psychiatric history for several reasons. For example, 
paediatricians or neurologists may have been more prone to focus on prior somatic 
than psychiatric history when assessing the patients. Thus, the data abstracted from 
the medical records in study Ⅰ is incomplete, and the numbers reported in study Ⅱ must 
be considered more reliable as we expect data completeness to be higher in Study Ⅱ 
than in Study Ⅰ. 
Prior studies have reported an occurrence of comorbid psychiatric disorders in 
children and adolescents with PNES varying from 16% to 100%.76 This variation may 
be due to methodological differences in PNES inclusion criteria, differences in study 
populations and study settings in terms of level of hospital care and differences in how 
psychiatric disorders were assessed. Most prior studies on psychiatric comorbidity in 
pediatric-onset PNES were performed using small sample sizes and without 
comparison groups. Still, the literature review of this thesis identified four more 
comprehensive studies. Pooling the results of these studies allows us to give a 
thorough account of psychiatric disorders in children and adolescents with PNES. The 
four studies are discussed in the below paragraph, and methods and results are 
outlined, and parallels are drawn to the results of Study Ⅱ.   
A study from the US published by Plioplys et al.64 in 2014 included 55 children and 
adolescents with PNES and their 35 siblings as well. The subjects were in the age 
range 8-18 years, and the study was conducted as a multisite study recruiting 
participants from tertiary epilepsy clinics. All PNES diagnoses were confirmed with 
a video EEG evaluated by a paediatrician with expertise in seizures, and a child 
psychiatrist assessed the PNES diagnosis. Comorbid psychiatric disorders were 
assessed using a semi-structured diagnostic instrument (K-SADS), and a blinded co-
investigator assessed the comorbid diagnoses and viewed a recording of the semi-
structured interview. The included children and adolescents with PNES had a mean 
age of 14.8 years and 71% were females; thus, the demographics were very similar to 
those of the PNES cohort in Study Ⅱ. In the study by Plioplys et al.,64 29.1% had 
comorbid epilepsy; which is higher than reported for Study Ⅱ (14.2%); this difference 
may impair the comparability of the study samples. All PNES cases in the study were 
assessed to have multiple psychiatric diagnoses, which was also the case for 45.7% of 
the siblings. Regarding specific diagnoses, significantly more of the PNES cases than 
of their siblings had anxiety, depression and PTSD. Among the PNES cases, 83% had 
anxiety, 43% had depression and 25% had PTSD. No significant differences between 
the groups were seen for ADHD and learning disorders; still, among PNES cases, 29% 




from Study Ⅱ, Plioplys et al. reported substantially higher numbers of psychiatric 
comorbidity in pediatric-onset PNES both overall and for specific diagnoses. 
An Australian study performed by Kozlowska et al.80 recruited 60 children and 
adolescents with PNES in the age range 8-17 years during the period 2011 to 2016. 
Patients were referred to a Psychological Medicine team for treatment after a 
neurology department had established the PNES diagnosis. The mean age at inclusion 
was 13.5 years, and 70% were females; thus, the population was younger than the 
population included in Study Ⅰ. Psychiatric comorbidity in PNES cases was described 
based on DSM-Ⅳ criteria, but the paper supplied no information on whether 
clinicians used diagnostic instruments as part of their assessment. A total occurrence 
of any psychiatric disorder was not provided, but 37% had anxiety disorder, 12% had 
PTSD, 12% had panic disorder, 17% had depression, 5% had behavioural disorder 
and 2% had eating disorder. The numbers reported by Kozlowska et al.80 are lower 
than the results reported by Plioplys et al.64 but more similar to the results from Study 
Ⅱ. Mood disorders were frequent; however, Kozlowska et al. did not clearly state 
whether the total range of psychiatric disorders had been assessed. 
A third study from the US by Luthy et al.78 was conducted as a retrospective cohort 
study using data from an administrative database of 49 North American Children’s 
hospitals in the period 2004 to 2014. The study included children and adolescents in 
the age range 8-20 years who had a registered diagnosis of PNES or epilepsy. PNES 
cases were included based on a registration with either of the ICD-9 diagnoses 
“Conversion disorder” (ICD-9: 300.11) or “Other convulsions” (ICD-9: 780.39).  
PNES cases were excluded if, prior to their PNES diagnosis, they were registered in 
the database with chronic somatic disorder diagnoses, suicide attempts, infections, 
trauma or pregnancy. Furthermore, PNES cases were excluded if they had a 
concurrent, registered epilepsy diagnosis or somatization disorder. The same 
exclusion criteria applied to patients included in the epilepsy cohort of the study who 
were identified if they were registered with a diagnosis of epilepsy (ICD-9: 345.00-
345.91). Thus, the study by Luthy et al.78 defined their PNES and epilepsy cohort 
using a comprehensive retrospective register data approach, but several limitations 
challenge the generalizability of the results. The study focused on PNES cases without 
comorbid epilepsy as cases with concurrent epilepsy were excluded. A further 
selection bias was introduced since the exclusion criteria barred recruitment of 
patients with a broad range of prior somatic disorders and patients with a concurrent 
somatization disorder, which is reported to be a common pathology in children and 
adolescents with PNES.57 Furthermore, Luthy et al.78 did not validate the PNES 
diagnosis nor did they use matching when including the epilepsy cohort. Thus, the 
following results of this study should be interpreted with caution. A total of 399 
patients were included in the PNES cohort, 72% were female and most were 14-16 
years old. In the PNES cohort, the study demonstrated that 26% had anxiety disorder, 
10% had bipolar disorder, 8% had depressive disorder and 8% suffered from a trauma 
or stress-related disorder. A total of 41% were reported to be registered with any of 
these disorders, and the remaining spectrum of psychiatric disorders were not 




methodology of the study hamper comparison of the findings with the results 
demonstrated in Study Ⅱ of this thesis. 
Finally, a UK study performed by McWilliams et al.77 studied 59 children and 
adolescents with PNES from 2012 to 2016. The study was a retrospective review of 
medical records from a tertiary children’s hospital, and clinical assessment was 
performed by a multidisciplinary team from both psychiatry and neurology. The 
PNES diagnosis was assessed using video EEG and was based on a specialist’s 
clinical evaluation. Diagnostic psychiatric assessment was performed involving a 
consultant psychiatrist and using ICD-10 diagnoses. A total of 63% were female and 
37% had comorbid epilepsy diagnosis. A comorbid psychiatric disorder was identified 
in 50% of PNES cases, and 17% had comorbid autism spectrum disorder (ASD), 9% 
had an ADHD diagnosis and 7% had intellectual disability. PNES cases with ASD 
were significantly more likely to have ADHD and tics than PNES cases without ASD. 
McWilliams et al.77 reported a lower percentage of females and a higher occurrence 
of comorbid epilepsy among cases with PNES than Study Ⅱ. Though patients were 
recruited at a tertiary hospital, the reported occurrence of any psychiatric comorbid 
disorder was similar to the results of Study Ⅱ which were based on cases from all 
levels of hospital-based care, but lower than reported by Plioplys et al.64 Still, the 
reported occurrence of ASD was substantially higher than reported in Study Ⅱ, which 
may be explained by the fact that neurodevelopmental disorders are more common 
among males than among females and are associated with epilepsy.120,147 
 
In summary, as suggested by previously published studies, the findings from Study Ⅱ 
demonstrate an increased risk of psychiatric disorders in children and adolescents with 
PNES compared with children and adolescent with epilepsy as well as children and 
adolescents with no PNES or epilepsy. Study Ⅱ outlines a broad spectrum of 
psychiatric disorders associated with PNES, as indicated in previously published 
literature. A thorough clinical psychiatric assessment of children and adolescents with 
PNES is important since unidentified psychopathology may perpetuate PNES and 
have a negative impact on both social and school functioning in the affected children 
and adolescents. 
   
5.4. HOSPITAL SERVICE USE 
Study Ⅲ was performed as a nationwide matched cohort study and demonstrated that 
children and adolescents with PNES used more hospital services in the 2 years leading 
up to their PNES diagnosis and in the 2 years after having received their PNES 
diagnosis.140 The majority of the contacts took place in somatic hospital settings, and 
somatic service use peaked in the year preceding the PNES diagnosis. After they had 
been diagnosed, children and adolescents with PNES continued to use more somatic 
services than the children and adolescents with epilepsy and HCs. Most of the children 
and adolescents with PNES had no registered contacts to psychiatric hospitals in the 




Based on these findings, Study Ⅲ thus shows that PNES in children and adolescents 
impose a considerable burden on the healthcare system, especially due to contacts in 
the somatic hospital setting. As mentioned in chapter one of this thesis, children and 
adolescents with epilepsy are known to have increased morbidity compared with 
children and adolescents from the general population.121 Study Ⅲ now provides 
evidence that increased morbidity associated with childhood-onset PNES is also an 
important issue that warrants attention.  
As mentioned above, most of the hospital services used by children and adolescents 
with PNES were offered by the somatic hospitals, and the majority of children and 
adolescents with PNES received no psychiatric hospital care after having received 
their PNES diagnosis. The design used in Study Ⅲ did not allow us to elicit 
information on the cause leading to the hospital contact or the treatment. Thus, we 
were not able to conclude whether children and adolescents with PNES received 
relevant care or not; still, they continued to have a high use of hospital services after 
receiving their PNES diagnosis, which could indicate that relevant treatment was not 
supplied. In Denmark, children and adolescents with PNES have traditionally been 
managed solely in paediatric departments as treatment options in psychiatric care have 
been scarce. A survey of Danish neuro- and social-paediatricians demonstrated that 
only 13% found existing treatment options to be sufficient; nevertheless, only 23% of 
the neuro-paediatricians often referred their patients to child and adolescents 
psychiatric care.99 The Danish Health Authority has recently outlined a clinical 
recommendation stating that the most severe cases of children and adolescents with 
functional disorders should be offered treatment in collaboration with the child and 
adolescent psychiatric departments.148 Treatment options in Danish paediatric 
departments vary across the country with some paediatric departments offering 
psychological care as part of the treatment. However, the findings of Study Ⅱ and 
Study Ⅲ of this thesis suggest that a closer collaboration between somatic and 
psychiatric healthcare professionals is needed to ensure relevant treatment of both 
neurological and psychological symptoms. Ibeziako and colleagues has recently 
published a description of a clinical pathway for SSRDs in pediatric hospital 
settings,149 which outlines a number of key steps from admission to discharge of 
children and adolescents with functional somatic symptoms in the attempt to provide 
a systematic standardized care. Clinical care pathways could give a standardization of 
care to ensure a close integrated multidisciplinary collaboration between the pediatric 
and child and adolescent psychiatric departments.  
The literature review outlined in chapter one of this thesis identified a very limited 
number of prior studies on healthcare use in childhood-onset PNES. Still, the findings 
of these studies are in line with the findings of Study Ⅲ, and they testify to an 
increased use of somatic emergency room visits and hospitalizations among patients 
with childhood-onset PNES compared with their siblings and with children and 
adolescents with epilepsy.63,64,96 The study by Luthy et al.78, discussed in the section 




children with epilepsy than for children with PNES; however, the study had several 
limitations introducing selection bias, and it only reported on costs associated with the 
incident hospital admission where the children received their PNES or epilepsy 
diagnosis.78 The findings demonstrated in Study Ⅲ included the complete use of 
hospital-based care covering a period from 2 years before until 2 years after the PNES 
diagnosis, thus providing results based on very robust and reliable data.     
In total, the findings suggest that efforts are needed to reduce the healthcare use of 
children and adolescents with PNES and to ensure access to appropriate treatment, 
which may improve patient outcomes and lower hospital-based care costs. Specialized 
treatment approaches involving multidisciplinary, integrated physical and mental 
healthcare have been suggested in previous studies.18,86,103–106 Future research should 
focus on strengthening the evidence base of treatment of paediatric-onset PNES by 
developing treatment models and protocols that should be assessed in RCTs. Such 
research could improve treatment options and decrease the burden on healthcare 
systems associated with this disease.  
 
5.5. STRENGHTS AND LIMITATIONS OF THE PHD PROJECT 
It is important to acknowledge that all research methodology holds limitations, and 
these limitations may influence the findings and conclusions of the research 
undertaken. When conducting an observational cohort study, the internal and external 
validity should be assessed.150 The internal validity describes how well a study can 
rule out alternative explanations of the demonstrated findings, also described as the 
degree of confidence in that potential confounders cannot explain the observed results. 
The external validity is the extent to which the demonstrated findings can be 
generalized beyond the study sample. This section will discuss the strengths and 
limitations of the methodology used in the three studies of this dissertation. 
A great strength of this PhD project is its population-based design, the use of 
nationwide data and the comprehensive systematic validation of individuals included 
in the PNES cohort. The use of register data enabled inclusion of a large study sample 
over a period spanning 2 decades and allowed inclusion of two matched comparison 
groups. Every citizen in Denmark has access to public healthcare free of charge, and 
since all hospital-based service use is documented in the Danish nationwide patient 
registries,128 the risk of selection bias is minimized and the external validity of the 
register data is considered to be high.  
The methodology used when establishing the PNES cohort in Study Ⅰ had many 
strengths. Study participants were identified using two register diagnoses and they 
were recruited from both specialized tertiary care and secondary less specialized 
hospital care. A total of 96% of the eligible hospital departments accepted to 




study participants. Furthermore, a thorough validation of the PNES diagnoses was 
performed, including a co-rating performed by both a consultant child and adolescent 
psychiatrist and a consultant neurologist.  
Still, a number of limitations should be noticed. Two register diagnoses (ICD-10: 
F44.5 and R56.8G) were chosen as a definition of PNES. As previously outlined, 
consensus regarding which ICD-10 diagnoses to use when diagnosing PNES is 
lacking,12 and a number of different register diagnoses may have been used to define 
PNES throughout the study period. On this background, an uncertain number of 
paediatric PNES cases may have been missed when establishing the cohort, which 
could bias the reported incidence rates and lead to a possible underestimation. 
Furthermore, a possible selection bias could also exist, as cases registered under 
different diagnoses may have other clinical characteristics. Nevertheless, the 
validation of the two included register diagnoses showed a high PPV, and using less 
specific register diagnoses would have made the number of study participants too 
large to ensure a validation of each participant as part of this PhD project due to 
pragmatic considerations.  
The case validation included the use of an adapted version of the ILAE criteria.35 The 
adapted criteria included clinical characteristics and witnessed seizure semiology, 
whereas EEG testing was necessary only to achieve the highest level of diagnostic 
certainty for PNES. The criteria were adapted to enable inclusion of the PNES cohort 
from both secondary and tertiary hospital-based care settings, since access to video 
EEG testing mainly exists in tertiary care in Denmark. The aim was to include a less 
selected sample of PNES cases, as most prior studies have included small samples 
from tertiary care, possibly raising issues regarding the external validity as these cases 
could be expected to be more severe and have higher morbidity. The gold standard of 
a PNES diagnosis is to have an ictal video EEG confirming the diagnosis; however, 
only including patients having undergone ictal video EEG testing would have 
decreased the generalizability to paediatric-onset PNES in the general population.  
 
We based validation of the PNES diagnosis and the description of the clinical 
characteristics in Study Ⅰ on data abstracted from medical records by the primary 
investigator (the PhD candidate, ASH). The quality of these data is closely linked to 
the meticulousness with which they have been recorded by the healthcare 
professionals, which means that issues may exist regarding their completeness. Still, 
the rating of the PNES diagnosis included an assessment of whether the medical 
record data were sufficient to perform the rating, and only nine 9 cases were excluded 
based on these considerations.   
 
A limitation of Study Ⅰ was the lack of a comparison group. It could have been 
interesting to compare the clinical characteristics reported in the study to the 
characteristics of either a group of children and adolescents with epilepsy or a group 
of HCs, as this could have disclosed the strength of the association with PNES. The 
study design in Study Ⅱ and Study Ⅲ enabled the inclusion of comparison groups, 




gender and age distribution as well as year of inclusion in the included study 
populations and to increase the internal validity of the findings. It should be noted that 
children and adolescents with epilepsy as well as HCs represent highly selected study 
samples due to matching on gender and age, and it is important to be careful not to 
generalize the numbers reported in Study Ⅱ and Study Ⅲ to all cases of epilepsy and 
children and adolescents from the general population.  
 
An additional strength is the long study period, lasting 2 decades, which was possible 
due to the retrospective register-based research design. The study period, 1996 to 
2014, was chosen for two reasons. First, the ICD-10 diagnostic system was 
implemented in Denmark in 1995, and the shift from the ICD-8 to the ICD-10 
diagnoses could introduce data inconsistency in the initial phase due to changes in 
coding practice. Thus, the study period was initialized in 1996 to allow a washout 
period and thereby diminish the risk of information bias. Second, the study period was 
set to end in 2014 to ensure completeness of the register data during the 2-year follow-
up period requiring data capture up until 2016.  
 
Every Danish citizen is registered in national healthcare registries. Nationwide data 
on hospital-based care are therefore available, and data may be extracted with a 
minimal risk of loss to follow-up since individuals are censored from the registries 
only in case of death or upon immigration from Denmark. This reduces the risk of 
bias arising from sampling as well as attrition. 
As described above, the PPVs of the two PNES inclusion diagnoses used in Study Ⅰ 
were high,131 and previous literature has reported that the PPV of the epilepsy register 
diagnosis is high as well.151 Thus, the external validity must be considered high in 
both the PNES cohort and the epilepsy control group. The validity of the included 
psychiatric ICD-10 diagnoses has been investigated for some of the diagnoses, 
showing varying PPVs,152,153 but the majority of the included psychiatric diagnoses 
have not been validated in a paediatric population. Still, children and adolescents who 
were registered with a psychiatric hospital contact and a psychiatric diagnosis must 
be considered to have passed a disease severity threshold warranting psychiatric 
hospital-based care. Some level of misclassification may be present in the included 
data on psychiatric diagnoses, but the numbers reported in Study Ⅱ are expected to 
reflect a degree of psychopathology too severe to be treated in primary care, thus 
demonstrating the presence of severe mental health problems in the study populations.     
 
For Study Ⅲ, the external validity must be considered high, as register data cover all 
hospital-based service use in the PNES cohort and as censoring was minimal in both 
the epilepsy control group and HCs after study inclusion. Danish register data are 
considered to have a high completeness; however, inconsistencies due to errors in data 
documentation or changes in coding practice are inevitable.128 These errors are 
considered random and equally present among individuals in the study, and data 






Overall, the PhD project had many strengths, but limitations were also noted that 
should be considered when interpreting the findings. Still, all three studies on which 
the present PhD dissertation is based had high internal and external validity, wherefore 
the findings of the PhD project may be considered trustworthy and applicable to the 









CHAPTER 6. CONCLUSIONS 
Psychogenic nonepileptic seizures (PNES) in children and adolescents lead to distress 
and impairment with school absenteeism and disruption of daily functioning for the 
affected patients. PNES impose a profound burden on patients and their families; even 
so, a treatment gap is described as diagnosis and treatment of the disorder intersect 
somatic and mental healthcare. Paediatric-onset PNES can be difficult to recognize 
and diagnose in the clinical setting as seizure symptoms mimic more commonly 
encountered disorders like epilepsy. This may delay diagnosis and lead to increased 
use of healthcare services due to misdiagnosis and repeated clinical examinations. 
Nevertheless, the literature review of this thesis demonstrated that previous 
knowledge on paediatric-onset PNES is based on a limited level of evidence which 
warrants further research. 
 
This PhD project aimed to establish a large cohort of children and adolescents with 
PNES and thereby increase the evidence base regarding incidence, characteristics and 
morbidity of childhood-onset PNES. Based on a population-based cohort design, the 
findings demonstrate a marked increase in the number of children and adolescents 
diagnosed with PNES from 1996 to 2014 in Denmark. Incidence rates were observed 
to be highest in female adolescents, and the highest rates were reported in 2014. More 
than every tenth paediatric patient with PNES had a concurrent epilepsy diagnosis, 
and a larger fraction of children and adolescents with comorbid epilepsy had 
intellectual disabilities, received support in school and were diagnosed with PNES 
later than the children and adolescents without comorbid epilepsy. Thus, comorbid 
epileptic seizures appeared to increase morbidity.  
Furthermore, based on the results from this PhD project, it can be concluded that 
children and adolescents with PNES are at higher risk of psychiatric disorders than 
children and adolescents with epilepsy and children and adolescents with no PNES or 
epilepsy. Elevated risks were observed for a wide spectrum of psychiatric disorders, 
which underline the importance of a careful psychiatric assessment and an 
individualized treatment plan when managing childhood-onset PNES. 
Finally, the PhD project demonstrated that children and adolescents with PNES have 
a higher use of hospital services in the 2-year period before and 2-year period after 
receiving their PNES diagnosis, compared with children and adolescents with 
epilepsy and children and adolescents with no PNES or epilepsy. Hospital services 
were provided mainly by somatic hospitals, and the majority of children and 
adolescents received no psychiatric hospital care after their PNES diagnosis. The 
findings underscore that childhood-onset PNES impose a considerable burden to 
hospital-based care and indicate that children and adolescents with PNES do not 
receive relevant care after their PNES diagnosis, since the offered treatment was not 





In conclusion, the present PhD project is the first of its kind to establish a nationwide 
validated cohort of children and adolescents with PNES. The increasing incidence 
rates and the associated morbidity, in terms of psychiatric disorders and primarily 
somatic hospital service use demonstrated in paediatric-onset PNES, suggest a need 
for an integrated multidisciplinary care approach to ensure proper recognition and 

























CHAPTER 7. CLINICAL IMPLICATIONS 
AND FUTURE RESEARCH 
The present thesis reported rising incidence rates of paediatric-onset PNES, a high 
associated burden of psychiatric disorders and elevated hospital service use in children 
and adolescents with PNES. These findings highlight that pediatric-onset PNES 
should be recognized as a disorder in need of relevant treatment options; moreover, 
the heterogeneous manifestation and wide spectrum of psychiatric disorders 
associated with paediatric-onset PNES suggest a need for integrated physical and 
mental healthcare pathways. This need is also voiced in extant literature, and it is 
recommended that management and treatment of functional disorders, including 
PNES, take place in close collaboration between somatic and psychiatric healthcare 
professionals.  
 
The high occurrence of psychiatric disorders in children and adolescents with PNES 
indicates that careful psychiatric evaluation should be considered in every young 
person affected by PNES to determine if psychiatric treatment is needed. If psychiatric 
care is not deemed to be necessary, the psychiatrist’s role could be to give expert 
advice and supervision to the patient’s supporting network including the healthcare 
professionals in charge of the patient’s treatment. A stepped-care approach to 
management of PNES could help clarify the care pathways and bridge the gap 
between mental and physical healthcare, as well as ensure that patients receive 
relevant treatment. Additionally, the high risk of developing psychiatric disorders in 
the years following the PNES diagnosis could suggest a need for continued close 
collaboration with the mental health specialist to monitor any new psychopathology. 
Improved clinical care pathways and treatment guidelines for paediatric-onset PNES 
may be a way forward to reduce morbidity in this young patient group, which may as 
well decrease the burden of healthcare utilization. 
 
The growing interest in paediatric-onset PNES is reflected in the emerging research 
evidence seen in recent years; still, further research is warranted as the current level 
of evidence remains limited. Future research should address variables associated with 
paediatric-onset PNES to improve recognition of this disorder and help distinguish 
PNES from other paroxysmal disorders like epilepsy. A prospective observational 
cohort study design could be used to outline risk factors and clinical characteristics in 
children and adolescents developing PNES compared with those developing epilepsy 
and with children and adolescents from the general population. Psychiatric morbidity 
in children and adolescents with PNES was described in detail in this thesis; however, 
potential somatic morbidity associated with pediatric-onset PNES should also be 
explored in further detail. Regarding the healthcare utilization in children and 
adolescents with PNES, prior lifetime healthcare use including contacts to general 




could further clarify the associated burden of healthcare use and inform future 
provision of healthcare services to this group of patients.  
Future research should also explore clinical care pathways and assess treatment 
protocols for paediatric-onset PNES. Randomized clinical trials on treatment 
exploring outcomes such as healthcare use, daily functioning, seizures remission and 
quality of life could improve the evidence base for treatment guidelines to be 
implemented in in the clinical setting. A multi-centre study could offer the opportunity 
to include a larger number of children and adolescents with PNES across hospital-
settings in Denmark or across countries, and this could enable more comprehensive 
trials of integrated care approaches to help coordinate the clinical pathways and bridge 
the gap between the somatic and psychiatric settings. 
 
Finally, knowledge dissemination and growing awareness of PNES are important to 
make patients, their families, and lay people more familiar with this disorder. 
Healthcare professionals also lack knowledge about PNES; thus, training in 
management of functional disorders typically constitutes only a very small part of the 
healthcare professionals’ curriculum. Patients with PNES and their families often 
experience stigma, which may be addressed through information facilitating a change 
in the attitude among lay people and healthcare professionals. Increased awareness 
can be achieved by developing patient information leaflets or webpages, by giving 
talks on PNES in local communities, by ensuring proper formal training of clinicians 
in assessment and management of PNES, and by developing national consensus 
guidelines on clinical care pathways and treatment of paediatric-onset PNES. An 
important step forward is to increase awareness of PNES and highlight the fact that 
PNES should be recognized as a complex disorder in need of access to 
multidisciplinary treatment options to decrease the burden of impairment, distress and 
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Appendix A. Literature search 
Definition of search terms by block building strategy: 
 AND 
OR 
Aspect 1: PNES Aspect 2: Children and adolescents 
PNES 
Psychogenic nonepileptic seizures 
Psychogenic non-epileptic seizures 





Non epileptic seizures 
NEAD  
Nonepileptic attack disorder 
Non-epileptic attack disorder 







Results of the database search: 
Databases Search performed 
Medline Terms: text words and MeSH 
 
Restrictions: Years: none. Language: none. 
 
Date of last search: 1 October, 2020 
 
Number of results: 769 
 
Embase Terms: free text and Emtree 
 
Restrictions: Years: none. Language: none. Publication type: no 
conference abstracts. 
 
Date of last search: 1 October, 2020 
 
Number of results: 821 
 
PsychINFO Terms: key words and Thesaurus 
 
Restrictions: Years: none. Language: none. 
 
Date of last search: 1 October, 2020 
 







Appendix A – continued. 
 






















Articles identified through database search: 
 
Medline: n = 769 
Embase: n = 821 
Psychinfo: n = 522 
 




Articles after duplicates removed: 
n = 1,468 
 
Articles identified after title and abstract 
screening: 
n = 261 
Articles assessed to describe the topic of children 
and adolescents with PNES: 
 
Original research and case reports:  n = 86 
Reviews: n = 10 
Other types of articles: n = 23 
 
Total, N = 119 
Duplicates removed: 
n = 644 
Articles excluded by title and 
abstract: 
 
n = 1,207 
Articles excluded after full text 
assessment: 








































































































Data extracted Definition 
Clinical examinations EEG: subtype performed (ictal-EEG, interictal-EEG, ictal-video-
EEG, interictal-video-EEG) and result (normal activity, 
abnormal epileptiform activity (both generalized and focal), 
abnormal non-epileptiform activity, EEG description not found). 
Cerebral MRI/CT: result (normal, changes clinically relevant for 
epilepsy, unspecific changes, not described). 
Neurological assessment: result registered if performed (normal: 
yes/no), and whether performed by neurologist or pediatrician. 
Psychiatric assessment: result registered if performed (normal: 
yes/no), and whether performed by a psychiatrist. 
Hospital information Type of hospital department: pediatric, neurology, child and 
adolescent psychiatric or other type of department. 
In- or outpatient status: admitted as inpatient or outpatient. 
Reason for referral: seizures, fainting or dizziness, other reason 
or not described. 
Seizure characteristics Time from onset to diagnosis was defined as the time from the 
first seizure reported in the patient history and up to the 
diagnosis of PNES. 
Frequency and duration of seizures were registered based on the 
information described in closest proximity to the time of 
inclusion.  
Stress in context with seizures included any description of being 
stressed in close proximity with having seizures. 
Trigger in context with onset of seizures included any event 
defined by the clinicians in the medical notes as a possible 
trigger. 
Seizure semiology In presence of others: seizure while other people around. 
Not during sleep: no seizures while sleeping. 
Asynchronous movements: asynchronous movements of limbs. 
Long duration: seizures lasting more than five minutes. 
Silent seizures: dialeptic seizures characterized by impaired 
consciousness and no motor activity. 
Rapid postical orientation: regained consciousness within few 
minutes after the seizure. 
Gradual onset: seizure beginning with mild symptoms and 
becoming more severe gradually. 
No incontinence/tongue biting: no urinary or fecal incontinence 
and tongue biting present during seizure. 
Fluctuating pattern: seizure symptoms varying in type and 
severity during the seizure. 
Closed eyes: resist eyelid opening. 
Attained consciousness: response when addressed during seizure. 
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Data extracted Definition 
Seizure semiology Ictal hyperventilation: abnormal increased respiratory rate during 
seizure.  
Pre-ictal hyperventilation: abnormal increased respiratory rate 
just before onset of the seizure. 
Emotional features: smiling, laughing, crying or gasping during 
seizure. 
Head movement from side-to-side. 
Hip movements: pelvic thrusting. 
Vocalization/ictal crying: especially in the middle or ending of 
the seizure. 
History of illness Patient history of illness: prior epilepsy diagnosis (defined as any 
type of epileptic disorder), prior psychiatric diagnosis (defined as 
any psychiatric disorder), and self-harm behavior prior to the 
diagnosis of PNES (defined as any suicidal attempt, suicidal 
ideations or self-harm). 
Family history of illness: prior epilepsy or psychiatric diagnosis 
as defined for patient history of illness. Registered for any first-
generation family member: father, mother or sibling. 
Prior treatment Included: psychotherapy (defined as any contact to a 
psychotherapist), and prior use of psychopharmacological or 
anti-epileptic medicine. 
Level of functioning School problems: defined as any school truancy, school refusal 
or sick leave. 
Support in school: defined as any special education or contact to 
a school psychologist. 
Low IQ: defined as a described intelligence quotient below 70. 
Specific learning difficulties: defined as any problems with basic 
skills (reading, writing or math as well as organization or time 
planning).  
Family characteristics Included: The living situation (living with parents or living in 
foster care/children’s institution), whether the parents were 
divorced, and if support was provided in the home by the social 
services. 
Negative life events The presence of negative life events prior to the diagnosis of 
PNES was identified based on a defined list of selected sub-items 
from the Childhood Traumatic Events Scale (Childhood Trauma 
Questionnaire, CTQ), and the Adverse Childhood Experiences 





Appendix D. Psychiatric disorder categories 
Definition of psychiatric disorder categories. 
Psychiatric disorders ICD-10 codes  ICD-8 codes 
Emotional disorders (includes anxiety, 
OCD and depression, bipolar disorder)  
F30-F39 
F40-F42 
F93, F98 (excluding DF98.8C) 
296.x9 (excluding: 296.89), 298.09, 
298.19, 300.49, 301.19 
300.x9 (excluding: 300.49, 300.5-7) 
Adjustment, PTSD and attachment 
disorders 
F43, F94 307, 308.4 
 
Neurodevelopmental disorders (ASD, 




299.00, 299.01, 299.02, 299.03 
306.1, 306.x9, 308.xx (excluding: 
306.1, 306.3, 308.4) 
Intellectual and specific learning 
disabilities 
F70-F79, F80-83 311.xx, 312.xx, 313.xx, 314.xx, 315.xx, 
306.1 
Somatic symptom and related disorders 
(excluding PNES) 
F44.XX (excluding F44.5), F45, F48 300.5-7 
305.xx (excluding 305.8, 305.9) 
Personality disorders F60, F61 301.x9 (excluding: 301.19), 301.80, 
301.81, 301.82, 301.84 
Psychotic disorders (includes 
schizophrenia, schizotypal, 
schizoaffective, and other psychotic 
disorders) 
F20-F29 295.x9, 296.89, 297.x9, 298.29-298.99, 
299.04, 299.05, 299.09, 301.83 
Eating disorders (includes anorexia 
nervosa and bulimia nervosa) 
F50 306.50, 306.58, 306.59 
Self-harm X60-X84 E950-E959, E980-E989 
Substance use F10-F19 291, 294.3x, 303.x9, 303.20, 303.28, 
303.90, 304.x9 
 
Definition of emotional and neurodevelopmental disorder subgroups. 
Psychiatric disorder Subgroups ICD-10 ICD-8 
Emotional disorders A. Anxiety disorders, 
incl. phobic, 
generalized and panic 
anxiety 
B. Mood disorders 
C. OCD 





A. 300.0-2, 300.4 








A. ADHD, ADD 
B. ASD 
C. Conduct disorders 
D. Tic disorders 





B. 299.00, 299.01, 
299.02, 299.03 
C. 308.1-2 
D. 306.2 
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